≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Thrombocytopenia, unspecified

DOID EFO Endpoint Browser PheWeb

D3_THROMBOCYTOPENIANAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D69.6
  • Hospital discharge: ICD-9 — 2875
  • Hospital discharge: ICD-8 — 28719|2872
  • Cause of death: ICD-10 — D69.6
  • Cause of death: ICD-9 — 2875
  • Cause of death: ICD-8 — 28719|2872

2 out of 7 registries used, show all original rules.

3071

4. Check minimum number of events

None

3071

5. Include endpoints

None

3071

6. Filter based on genotype QC (FinnGen only)

2962

Control definitions (FinnGen only)

Control exclude
D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D69
Name in latin
Thrombocytopenia NAS

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 20979 9790 11000
Only index persons 17647 8393 9254
Unadjusted period prevalence (%)
Whole population 0.29 0.28 0.31
Only index persons 0.33 0.31 0.35
Median age at first event (years)
Whole population 60.24 59.26 61.06
Only index persons 59.45 57.70 61.04

-FinnGen-

Key figures

All Female Male
Number of individuals 2962 1375 1587
Unadjusted period prevalence (%) 0.62 0.49 0.73
Median age at first event (years) 62.76 58.01 66.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3071
Matched controls
30705
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D70.82
ICD-10 Finland
Drug-induced neutropenia
21.5
307.7
300
154
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7644.4
307.7
625
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.0
307.7
551
658
WW500
NOMESCO Finland
Blood transfusion
14.4
307.7
636
546
D70.89
ICD-10 Finland
Neutropenic splenomegaly
22.8
307.7
270
129
XW000
NOMESCO Finland
Bone marrow biopsy
23.6
307.7
943
567
D64.9
ICD-10 Finland
Anaemia, unspecified
5.3
307.7
876
2144
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
16264.3
307.7
2914
35
L03AA02
ATC
filgrastim; parenteral
9.0
240.2
311
379
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
10.4
232.8
269
282
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.8
228.3
384
630
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
223.0
816
2576
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
79.1
200.3
107
14
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
195.7
708
2200
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
12.3
185.4
188
162
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.2
181.0
161
111
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
875.5
170.6
166
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.0
168.0
314
568
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
11.7
156.5
163
146
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
27.3
143.4
98
37
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
140.3
1885
11642
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
10.1
138.1
160
167
R50.9
ICD-10 Finland
Fever, unspecified
3.0
137.9
768
3057
JN6AD
NOMESCO Finland
CT of torso and neck
8.9
136.9
175
208
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
25.4
136.8
96
39
JN4AD
NOMESCO Finland
Body CT examination
3.3
134.9
623
2223
28719
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia NUD
+∞
133.3
127
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
133.2
504
1586
L03AA14
ATC
lipegfilgrastim; parenteral
8.7
125.0
161
193
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.8
123.8
104
64
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
13.8
120.7
113
85
ZX120
NOMESCO Finland
Intravenous
3.5
120.2
484
1579
L03AA13
ATC
pegfilgrastim; parenteral
4.9
117.6
274
600
JN4BD
NOMESCO Finland
Extensive body CT
3.2
115.7
528
1858
H02AB06
ATC
prednisolone; systemic
2.4
115.1
1744
10990
YNB10
NOMESCO Finland
Collection of stem cells for transplant
55.3
114.5
65
12
M04AA01
ATC
allopurinol; systemic
2.9
114.3
676
2753
H02AB02
ATC
dexamethasone; systemic
3.1
114.1
554
2021
WW300
NOMESCO Finland
Transfer of autologic stem cells
28.2
114.0
77
28
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
9.0
112.9
142
165
D69.5
ICD-10 Finland
Secondary thrombocytopenia
380.8
111.1
111
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
12.3
99.8
100
84
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.5
96.4
194
373
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
96.3
343
1027
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
94.2
759
3568
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
25.0
93.6
66
27
Z51.5
ICD-10 Finland
Palliative care
3.0
91.3
460
1701
A04AA02
ATC
granisetron; systemic, transdermal
3.5
91.0
335
1024
D68.8
ICD-10 Finland
Other specified coagulation defects
27.0
89.0
61
23
B02BX05
ATC
eltrombopag; oral
+∞
87.9
84
*
D69.4
ICD-10 Finland
Other primary thrombocytopenia
+∞
87.9
84
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
19.8
87.9
68
35
A04AA01
ATC
ondansetron; systemic, rectal
3.2
86.9
390
1347
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.0
85.8
190
397
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
84.1
1199
7100
C83.1
ICD-10 Finland
Mantle cell lymphoma
18.5
83.8
67
37
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
83.7
837
4301
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.6
83.0
299
900
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
35.2
82.4
52
15
J01MA12
ATC
levofloxacin; systemic
2.3
81.9
754
3735
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
44.3
80.6
48
11
C03CA01
ATC
furosemide; systemic
2.1
77.9
1174
7050
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
77.1
1076
6274
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
7.3
75.5
112
158
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
18.5
72.5
58
32
A02BC02
ATC
pantoprazole; systemic
2.1
71.5
2226
17082
ZX108
NOMESCO Finland
Inhalation
11.1
67.8
72
66
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
67.6
834
4603
1517, ,
Kela drug reimbursment
+∞
66.9
64
*
3039, ,
Kela drug reimbursment
+∞
66.9
64
*
6BA02, ,
NOMESCO Finland
22.6
66.9
49
22
N02AA05
ATC
oxycodone; systemic
2.2
65.7
737
3915
B03XA02
ATC
darbepoetin alfa; parenteral
5.0
65.5
146
306
WZC00
NOMESCO Finland
Treatment plan or consultation
1.9
64.7
1271
8237
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
62.9
261
855
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
11.4
61.4
64
57
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
16.9
60.0
50
30
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
58.9
193
543
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
58.4
977
5957
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.2
57.8
246
817
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
9.3
57.0
69
76
TGC00
NOMESCO Finland
Bronchial lavation
4.4
56.8
148
352
L04AD01
ATC
ciclosporin; systemic
5.7
55.7
106
193
ZXE00
NOMESCO Finland
One hour or less
1.8
55.2
1249
8351
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
54.2
514
2534
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
9.0
53.2
66
75
L01CB01
ATC
etoposide; systemic
10.5
52.7
58
56
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
9.1
52.0
64
72
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
22.6
51.8
38
17
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
50.6
442
2103
R18
ICD-10 Finland
Ascites
4.9
50.4
113
238
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
14.7
50.2
45
31
1XC02, ,
NOMESCO Finland
9.0
50.2
62
70
2875A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia, unspecified
+∞
50.1
48
*
127
Kela drug reimbursment
Transplant complication
5.6
48.3
93
171
H02AB09
ATC
hydrocortisone; systemic
4.2
47.1
127
310
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.5
46.5
91
170
B01AB10
ATC
tinzaparin; parenteral
2.3
45.1
404
1936
A05AA02
ATC
ursodeoxycholic acid; oral
5.6
45.0
86
157
ZXD05
NOMESCO Finland
Urgent procedure
1.8
44.8
965
6268
L04AA06
ATC
mycophenolic acid; systemic
4.8
44.5
102
219
R04.0
ICD-10 Finland
Epistaxis
2.5
44.3
316
1372
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
43.7
684
4021
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
43.6
202
703
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.9
43.5
78
134
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
43.2
826
5167
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
43.1
425
2115
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
62.2
42.3
49
8
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.7
42.1
79
142
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
12.2
41.9
42
35
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.6
41.9
101
226
ED1AA
NOMESCO Finland
Mandibular X-ray examination
8.1
41.8
56
70
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
13.1
41.7
40
31
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
14.2
41.6
38
27
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.6
41.3
142
412
XX3DW
NOMESCO Finland
Time consuming IT work
2.2
41.3
401
1983
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.5
41.2
101
229
A07AA11
ATC
rifaximin; oral
12.6
40.9
40
32
L04AX01
ATC
azathioprine; systemic
3.2
40.9
171
561
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
40.7
166
536
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
40.7
280
1194
AA1AD
NOMESCO Finland
CT of head and brain
1.7
40.3
983
6574
JMA10
NOMESCO Finland
Transabdominal total splenectomy
9.5
39.8
47
50
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
8.2
39.7
53
66
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
7.3
39.4
58
81
D69.1
ICD-10 Finland
Qualitative platelet defects
138.5
38.8
41
*
C03DA01
ATC
spironolactone; oral
2.0
38.5
449
2376
B01AB05
ATC
enoxaparin; parenteral
1.7
38.4
983
6642
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.6
37.9
91
203
ZX112
NOMESCO Finland
Subcutaneous
4.0
37.8
109
280
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.0
37.2
109
283
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
9.5
37.1
44
47
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.0
36.9
105
267
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
35.6
340
1666
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
11.0
34.7
37
34
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
34.6
409
2170
B02AA02
ATC
tranexamic acid; systemic
2.0
34.1
412
2202
WZC30
NOMESCO Finland
Teaching
1.8
34.0
565
3355
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
4.9
34.0
75
156
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
33.7
155
537
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
33.0
301
1446
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
33.0
167
610
H02AB07
ATC
prednisone; oral
1.9
32.9
445
2471
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.6
32.9
62
112
D64.8
ICD-10 Finland
Other specified anaemias
4.0
32.7
94
241
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
32.5
628
3895
2873A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]
+∞
32.3
31
*
D69.0
ICD-10 Finland
Allergic purpura
34.6
31.9
41
12
TK800
NOMESCO Finland
Hemodialysis
3.8
31.9
97
259
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
7.2
31.8
47
66
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
31.8
142
484
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
10.7
31.3
34
32
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.8
31.3
71
151
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
30.8
249
1137
122
Kela drug reimbursment
Aplastic anaemia
86.0
30.8
34
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.8
30.6
164
617
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
30.5
323
1643
N02AX02
ATC
tramadol; systemic, rectal
1.6
30.5
1295
9774
B02BX04
ATC
romiplostim; parenteral
+∞
30.3
29
*
A07AA09
ATC
vancomycin; oral
4.4
30.2
75
172
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
7.0
30.1
46
67
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
30.1
782
5245
Z94.4
ICD-10 Finland
Liver transplant status
10.4
29.8
33
32
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
29.4
1224
9173
R4110
NOMESCO Finland
Physiotherapy
1.6
29.2
851
5868
K92.1
ICD-10 Finland
Melaena
2.4
29.2
208
899
K70.4
ICD-10 Finland
Alcoholic hepatic failure
9.3
29.2
35
38
TPX15
NOMESCO Finland
Removal of vascular injection port
8.9
28.9
36
41
L04AD02
ATC
tacrolimus; systemic
5.5
28.8
56
104
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
10.8
28.7
31
29
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
28.6
438
2525
UJF32
NOMESCO Finland
Coloscopy
1.6
28.5
808
5527
K72.9
ICD-10 Finland
Hepatic failure, unspecified
7.4
28.4
41
56
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
28.4
116
375
Z3231
NOMESCO Finland
Registered nurse
1.6
28.3
837
5784
3038, ,
Kela drug reimbursment
+∞
28.2
27
*
1516, ,
Kela drug reimbursment
+∞
28.2
27
*
SPAT1088
SPAT
Blood transfusion
7.7
28.0
39
51
K70.1
ICD-10 Finland
Alcoholic hepatitis
7.7
28.0
39
51
J01DB01
ATC
cefalexin; oral
1.7
28.0
2448
21537
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
9.5
28.0
33
35
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
27.9
237
1105
J01MA14
ATC
moxifloxacin; systemic
2.1
27.7
301
1544
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
7.6
27.6
39
52
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
11.2
27.6
29
26
D73.1
ICD-10 Finland
Hypersplenism
47.6
27.4
33
7
WW200
NOMESCO Finland
Immunization
3.2
27.4
108
342
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
53.8
27.2
32
6
1524, ,
Kela drug reimbursment
+∞
27.1
26
*
3052, ,
Kela drug reimbursment
+∞
27.1
26
*
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
+∞
27.1
26
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.3
27.0
45
72
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
27.0
275
1377
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.9
26.9
80
210
A06AD11
ATC
lactulose; oral
1.8
26.9
493
2997
A41.8
ICD-10 Finland
Other specified sepsis
3.5
26.7
93
272
J05AB11
ATC
valaciclovir; oral
1.8
26.7
440
2592
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
26.4
489
2982
WPA13
NOMESCO Finland
Palliative consultation
7.6
26.3
37
49
Z2221
NOMESCO Finland
Medical doctor
1.6
26.3
794
5498
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.3
26.2
216
994
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.5
26.0
50
92
N05CF01
ATC
zopiclone; oral
1.6
25.9
948
6859
A46
ICD-10 Finland
Erysipelas
1.8
25.8
479
2919
A02BC01
ATC
omeprazole; systemic
1.6
25.6
805
5622
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
9.5
25.3
30
32
JN4CD
NOMESCO Finland
Very extensive body CT
2.7
25.2
141
543
B02BX08
ATC
avatrombopag; systemic
+∞
25.0
24
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
6.4
24.8
41
65
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.7
24.3
56
121
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
4.6
24.3
57
125
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
24.2
1035
7715
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
5.4
24.0
47
88
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.1
23.5
49
97
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
47.0
23.3
28
6
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
7.3
23.3
34
47
WX402
NOMESCO Finland
General anaesthesia
1.6
23.2
660
4485
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
5.4
23.2
46
87
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
7.4
22.9
33
45
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
7.2
22.9
34
48
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.8
22.8
116
425
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.3
22.7
84
256
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
27.5
22.2
30
11
212
Kela drug reimbursment
Gout
3.2
22.2
87
275
WX892
NOMESCO Finland
Monitored bed care
2.0
22.1
258
1356
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
5.0
21.8
47
96
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
21.8
232
1179
WX002
NOMESCO Finland
Sedation and analgesia
1.6
21.6
571
3806
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
21.2
531
3491
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.7
21.0
48
103
TAB00
NOMESCO Finland
Lumbar puncture
2.4
21.0
149
643
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
16.7
20.9
33
20
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
5.4
20.9
41
77
ZX131
NOMESCO Finland
Intrathecal
60.4
20.9
24
*
A10AB05
ATC
insulin aspart; parenteral
2.0
20.7
253
1349
J01MA02
ATC
ciprofloxacin; systemic
1.5
20.7
1142
8891
TGD00
NOMESCO Finland
Needle biopsy of lung
6.4
20.5
34
54
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
8.2
20.5
27
33
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.4
20.5
75
227
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
20.4
112
427
J01FF01
ATC
clindamycin; systemic
1.5
20.4
769
5546
N03AX14
ATC
levetiracetam; systemic
2.8
20.3
106
394
D68.9
ICD-10 Finland
Coagulation defect, unspecified
48.3
20.1
24
5
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
5.1
20.0
42
84
L01BB02
ATC
mercaptopurine; oral
4.4
19.9
49
112
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.0
19.8
56
142
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
19.8
255
1385
K29.6
ICD-10 Finland
Other gastritis
4.1
19.5
54
135
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
4.6
19.4
46
102
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
14.7
19.4
32
22
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
15.6
19.2
31
20
J02AC03
ATC
voriconazole; systemic
15.6
19.2
31
20
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
19.2
153
694
L01AX03
ATC
temozolomide; systemic
5.6
19.1
36
65
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
19.1
110
430
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
20.2
19.0
28
14
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.1
19.0
78
254
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
34.5
18.9
24
7
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
18.8
131
561
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
18.7
168
800
JJC00
NOMESCO Finland
Allogenic transplantation of liver
17.2
18.7
29
17
ZX121
NOMESCO Finland
Central venous catheter
7.4
18.6
27
37
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
18.6
2039
17813
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.4
18.5
46
106
B01AA03
ATC
warfarin; systemic
1.5
18.5
584
4044
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.1
18.5
50
123
K92.0
ICD-10 Finland
Haematemesis
2.8
18.3
92
335
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.0
18.3
51
128
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.4
18.2
64
189
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
5.3
18.0
36
69
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
52.8
17.9
21
*
P01BA02
ATC
hydroxychloroquine; oral
1.9
17.8
226
1221
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
17.8
993
7694
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.5
17.5
61
179
M35.1
ICD-10 Finland
Other overlap syndromes
6.6
17.5
28
43
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.5
17.3
59
171
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
17.3
148
692
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
17.2
790
5896
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.7
17.1
93
353
N03AX16
ATC
[U] pregabalin
1.5
17.0
626
4470
WF002
NOMESCO Finland
Radical radiotherapy
2.0
17.0
189
976
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
16.9
170
845
Z3226
NOMESCO Finland
Physiotherapist
1.6
16.9
515
3530
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
16.9
1446
12020
J01CA04
ATC
amoxicillin; systemic
1.5
16.6
2342
21148
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
16.5
207
1113
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
7.3
16.5
24
33
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
16.4
179
918
B99
ICPC
Blood/lymph/spleen disease other
6.1
16.4
28
46
Z31.5
ICD-10 Finland
Genetic counselling
2.2
16.3
142
668
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
16.3
662
4818
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
16.2
405
2651
N02BE01
ATC
paracetamol; systemic, rectal
1.5
16.2
2613
24152
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
3.2
16.0
64
205
WVA20
NOMESCO Finland
Medicine administration
2.5
16.0
99
401
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.6
16.0
30
54
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
16.0
76
269
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
21.1
16.0
23
11
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
16.0
196
1047
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.0
15.9
69
232
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
2.3
15.9
122
545
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
15.9
184
963
A03
ICPC
Fever
1.6
15.7
467
3180
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
15.7
238
1360
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.4
15.7
106
448
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
85.5
15.6
17
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
15.6
253
1476
L04AX03
ATC
methotrexate; systemic
1.8
15.5
267
1584
WX872
NOMESCO Finland
Intensive care
2.0
15.5
163
825
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.9
15.3
188
1005
C91.4
ICD-10 Finland
Hairy-cell leukaemia
28.7
15.2
20
7
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.4
15.0
54
162
WZC15, ,
NOMESCO Finland
4.2
15.0
39
93
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
15.0
300
1853
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
15.0
144
704
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
5.0
15.0
32
65
R31
ICD-10 Finland
Unspecified haematuria
1.6
15.0
329
2084
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
10.9
15.0
28
26
E0000UV, ,
ATC
1.4
14.9
1142
9264
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
14.9
531
3755
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
6.8
14.9
23
34
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.6
14.8
86
338
WPB10
NOMESCO Finland
Making a convalescent care decision
5.5
14.8
28
51
C90.0
ICD-10 Finland
Multiple myeloma
3.5
14.7
50
145
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.7
14.5
78
295
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
150.7
14.5
15
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
14.5
294
1825
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
36.2
14.4
18
5
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
36.2
14.4
18
5
WX882
NOMESCO Finland
High dependency care
2.4
14.3
101
435
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
4.2
14.3
37
88
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
27.3
14.3
19
7
A04AA55
ATC
palonosetron, combinations; systemic
2.3
14.3
104
455
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
4.1
14.2
39
97
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.8
14.2
43
115
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
14.2
279
1716
R60.0
ICD-10 Finland
Localized oedema
1.6
14.2
370
2443
K76.9
ICD-10 Finland
Liver disease, unspecified
3.4
14.1
49
144
R11
ICD-10 Finland
Nausea and vomiting
1.7
14.1
249
1487
R53
ICD-10 Finland
Malaise and fatigue
1.4
14.0
709
5357
N19
ICD-10 Finland
Unspecified kidney failure
2.1
13.9
130
629
K72.1
ICD-10 Finland
Chronic hepatic failure
15.8
13.9
22
14
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.6
13.9
78
302
130
Kela drug reimbursment
Malignant tumour
1.7
13.9
274
1687
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
13.8
356
2343
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
13.6
13.7
23
17
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
13.6
307
1955
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
6.5
13.6
22
34
28710
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia essentialis (Morbus Werlhof)
+∞
13.5
13
*
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.8
13.5
196
1104
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.4
13.5
90
378
B82
ICPC
Anaemia other/unspecified
2.3
13.5
101
447
Z2446
NOMESCO Finland
Social worker
1.8
13.5
191
1069
WF004
NOMESCO Finland
Palliative radiotherapy
2.6
13.4
78
307
J05AB01
ATC
aciclovir; systemic
1.4
13.4
578
4235
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
16.3
13.4
21
13
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
13.4
101
449
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
13.4
268
1657
B34.9
ICD-10 Finland
Viral infection, unspecified
2.4
13.4
87
362
M31.1
ICD-10 Finland
Thrombotic microangiopathy
25.8
13.4
18
7
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
25.8
13.4
18
7
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
13.3
1009
8136
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
21.2
13.3
19
9
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
13.3
447
3119
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
3.7
13.3
42
116
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
13.3
173
943
C07AB07
ATC
bisoprolol; oral
1.3
13.3
1398
11839
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
13.1
127
624
M10.9
ICD-10 Finland
Gout, unspecified
1.7
13.1
227
1349
WW409
NOMESCO Finland
Other aferesis
12.2
13.1
23
19
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
3.9
13.1
38
99
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
13.0
438
3057
306
Kela drug reimbursment
Erythropoietin and darbepoetin
6.1
12.9
22
36
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
12.9
175
967
D68.0
ICD-10 Finland
Von Willebrand disease
50.2
12.8
15
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.0
12.8
129
644
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.8
12.7
62
223
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.4
12.7
44
129
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.2
12.7
49
154
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
5.1
12.7
26
51
XX2RW, ,
NOMESCO Finland
3.1
12.7
52
170
N03AX18
ATC
lacosamide; systemic
4.4
12.6
31
71
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
70.1
12.6
14
*
I81
ICD-10 Finland
Portal vein thrombosis
5.5
12.6
24
44
ZX080
NOMESCO Finland
Image guided radiotherapy
2.6
12.6
71
276
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.6
12.4
70
272
B28
ICPC
Limited function/disability (B)
5.6
12.4
23
41
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
5.0
12.4
26
52
C07AG02
ATC
carvedilol; oral
1.8
12.4
178
1001
K29.7
ICD-10 Finland
Gastritis, unspecified
2.2
12.4
108
510
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.2
12.4
106
497
K08.3
ICD-10 Finland
Retained dental root
1.7
12.1
224
1354
A28
ICPC
Limited function/disability NOS
1.4
12.0
530
3893
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
12.0
444
3154
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
9.3
12.0
24
26
I50.0
ICD-10 Finland
Congestive heart failure
1.7
12.0
234
1437
S97
ICPC
Chronic ulcer skin
1.8
12.0
192
1116
R06.0
ICD-10 Finland
Dyspnoea
1.4
12.0
765
5989
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.1
12.0
108
517
N05BA04
ATC
oxazepam; oral
1.4
11.9
687
5286
E87.5
ICD-10 Finland
Hyperkalaemia
2.6
11.9
68
266
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.9
11.9
53
182
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
10.5
11.7
22
21
A06AH03
ATC
naloxegol; oral
2.9
11.7
54
189
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
11.7
228
1399
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
11.6
616
4673
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
11.6
369
2542
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
19.0
11.6
17
9
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.8
11.5
183
1060
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
11.5
78
331
K74.3
ICD-10 Finland
Primary biliary cirrhosis
5.0
11.5
24
48
B73
ICPC
Leukaemia
13.6
11.4
19
14
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.5
11.3
67
267
SPAT1262
SPAT
Handing over of treatment supplies
1.4
11.3
483
3525
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.0
11.3
128
666
B01AB04
ATC
dalteparin; parenteral
1.9
11.3
137
730
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.3
11.2
82
360
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
17.1
11.2
17
10
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
4.7
11.2
25
53
WW402
NOMESCO Finland
Leucoferesis
25.1
11.1
15
6
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
20.1
11.1
16
8
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
11.1
868
6996
A79
ICPC
Malignancy NOS
2.8
11.1
54
195
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
8.1
11.1
24
30
SPAT1255
SPAT
Intravenous administration of medicine
1.7
11.0
190
1129
AB2
HP
AVR bio, stent
4.4
11.0
27
62
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.5
10.9
26
58
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
10.9
513
3807
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
43.5
10.9
13
*
UKC02
NOMESCO Finland
Cystoscopy
1.4
10.9
474
3469
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.9
10.9
144
789
K76.7
ICD-10 Finland
Hepatorenal syndrome
11.9
10.8
19
16
K70.0
ICD-10 Finland
Alcoholic fatty liver
4.0
10.7
30
76
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.3
10.6
80
356
P01AB01
ATC
metronidazole; oral, rectal
1.3
10.6
1002
8281
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
10.5
170
992
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
110.4
10.4
11
*
J05AX18
ATC
letermovir; oral
110.4
10.4
11
*
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
5.4
10.4
20
37
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.9
10.4
30
78
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
10.4
502
3743
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
10.4
109
553
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
7.7
10.4
23
30
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
10.3
1148
9691
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.2
10.3
40
127
J02AC04
ATC
posaconazole; systemic
18.8
10.3
15
8
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
9.6
10.2
20
21
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
9.6
10.2
20
21
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
23.4
10.2
14
6
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
23.4
10.2
14
6
H02AB04
ATC
methylprednisolone; systemic
1.5
10.2
360
2530
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
10.1
73
319
TKC20
NOMESCO Finland
Catheterisation of bladder
1.7
10.1
199
1224
UJF92
NOMESCO Finland
Capsular endoscopy
2.4
10.1
65
270
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
4.5
10.0
24
54
R06
ICPC
Nose bleed/epistaxis
2.3
10.0
76
340
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.0
10.0
43
145
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
14.6
10.0
16
11
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.7
10.0
51
189
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
10.0
319
2198
A10AE04
ATC
insulin glargine; parenteral
1.5
10.0
273
1820
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.6
9.9
58
230
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.3
9.9
72
316
6753
FHL
Transabdominal splenectomy
16.7
9.9
15
9
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.8
9.9
49
179
TK810
NOMESCO Finland
Hemofiltration
4.3
9.8
25
59
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.4
9.8
67
286
AAA10
NOMESCO Finland
Biopsy through craniotomy
26.1
9.8
13
5
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
26.1
9.8
13
5
WX730
NOMESCO Finland
Conventional respirator
2.7
9.8
51
191
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
9.8
208
1306
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.8
9.8
133
737
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.5
9.7
61
251
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
9.7
206
1294
390
Kela drug reimbursment
Ibrutinib
13.4
9.7
16
12
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.9
9.6
110
575
L04AA01
ATC
[U] ciclosporin
3.1
9.6
39
127
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
2.5
9.6
60
246
B03XA01
ATC
erythropoietin; parenteral
3.4
9.6
33
97
R06AE07
ATC
cetirizine; oral
1.3
9.6
1102
9317
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
4.4
9.5
23
52
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.0
9.5
40
133
H05AA02
ATC
teriparatide; parenteral
4.8
9.5
21
44
WNF00
NOMESCO Finland
Infection source and contact determination
4.6
9.5
22
48
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
9.1
9.5
19
21
D69.8
ICD-10 Finland
Other specified haemorrhagic conditions
15.1
9.5
15
10
120
Kela drug reimbursment
Hypogammaglobulinaemia
15.1
9.5
15
10
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
9.4
157
923
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
3.2
9.4
36
113
126
Kela drug reimbursment
Chronic coagulation defects
+∞
9.4
9
*
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.1
9.4
89
436
K76.6
ICD-10 Finland
Portal hypertension
21.7
9.3
13
6
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
4.9
9.3
20
41
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.3
1130
9610
318
Kela drug reimbursment
Teriparatide
4.5
9.3
22
49
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
2.9
9.3
42
146
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
9.3
87
424
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.1
9.2
38
125
L01XX05
ATC
hydroxycarbamide; oral
2.9
9.2
42
147
QDA10
NOMESCO Finland
Incision of skin of lower limb
3.7
9.1
28
76
I50
ICD-10 Finland
Heart failure
2.0
9.1
93
467
ZXA10
NOMESCO Finland
Bilateral
1.4
9.1
472
3554
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.3
9.1
70
315
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
9.1
122
673
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
5.0
9.1
19
38
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.8
9.1
140
806
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
9.1
168
1018
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
2.7
9.0
48
182
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.0
9.0
97
497
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
3.3
9.0
33
101
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
18.6
8.9
13
7
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
24.1
8.9
12
5
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.3
8.9
32
97
W19
ICD-10 Finland
Unspecified fall
1.5
8.9
266
1809
L01BC06
ATC
capecitabine; oral
1.9
8.8
107
571
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.2
8.8
71
326
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.9
8.8
39
134
SPAT1263
SPAT
Sampling
1.3
8.8
1083
9209
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.8
8.8
126
710
R4190
NOMESCO Finland
Nutritional therapy
1.9
8.7
112
609
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
8.7
404
2984
N06AX11
ATC
mirtazapine; oral
1.3
8.7
873
7231
N02AA01
ATC
morphine; systemic, rectal
2.3
8.7
61
264
A98.5
ICD-10 Finland
Haemorrhagic fever with renal syndrome
2.4
8.7
57
240
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
2.9
8.6
40
141
I95.9
ICD-10 Finland
Hypotension, unspecified
2.4
8.6
55
228
A10AC01
ATC
insulin (human); parenteral
1.6
8.6
200
1283
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
7.6
8.6
19
25
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.3
8.6
64
284
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.3
8.6
31
94
S18
ICPC
Laceration/cut
1.3
8.6
1296
11281
ZX100
NOMESCO Finland
Oral
2.7
8.6
44
164
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
2.3
8.5
59
254
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.7
8.5
43
159
E83.50
ICD-10 Finland
Hypercalcemia
2.7
8.5
43
159
ZX114
NOMESCO Finland
Intramuscular
2.7
8.5
43
159
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
8.5
125
710
3AC01, ,
NOMESCO Finland
3.2
8.5
33
105
WW500, ,
SPAT
27.6
8.5
11
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.7
8.5
151
906
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.7
8.5
142
838
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
7.3
8.4
19
26
A02BC05
ATC
esomeprazole; systemic
1.3
8.4
1039
8827
A04AD12
ATC
aprepitant; systemic
2.4
8.4
54
225
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
8.4
27
76
1512
Kela drug reimbursment
Ibrutinib
12.8
8.4
14
11
L01AA01
ATC
cyclophosphamide; systemic
4.7
8.3
19
41
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
8.3
8
*
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
8.3
8
*
A91
ICPC
Abnormal result investigation NOS
1.7
8.3
151
911
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
9.5
8.3
16
17
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.1
8.2
72
342
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.2
8.2
32
102
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
8.2
274
1905
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.0
8.2
35
118
B02.9
ICD-10 Finland
Zoster without complication
1.6
8.2
186
1189
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
4.8
8.1
18
38
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
8.1
343
4622
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
8.1
993
8422
Z85.6
ICD-10 Finland
Personal history of leukaemia
33.4
8.1
10
*
D70
ICD-10 Finland
Agranulocytosis
33.4
8.1
10
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.2
8.1
63
286
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
11.7
8.1
14
12
L01EL01
ATC
ibrutinib; oral
22.1
8.0
11
5
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
22.1
8.0
11
5
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
22.1
8.0
11
5
K65.0
ICD-10 Finland
Acute peritonitis
2.9
8.0
36
125
TQW80
NOMESCO Finland
Local dermatologic skincare
2.1
8.0
73
353
J01AA02
ATC
doxycycline; systemic
1.3
8.0
2119
19588
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
8.0
146
883
B04
ICPC
Blood symptom/complaint
3.9
8.0
23
60
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
8.0
775
6386
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
7.2
7.9
18
25
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
7.9
456
3490
C09AA05
ATC
ramipril; oral
1.3
7.9
677
5485
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.7
7.9
146
885
R55
ICD-10 Finland
Syncope and collapse
1.5
7.9
295
2096
M05BA04
ATC
alendronic acid; oral
1.5
7.9
213
1416
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
6.6
7.9
19
29
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
4.6
7.9
18
39
D07AC01
ATC
betamethasone; topical
1.3
7.8
939
7935
RK320, ,
NOMESCO Finland
3.5
7.8
26
75
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
7.8
231
1567
D75.2
ICD-10 Finland
Essential thrombocytosis
3.9
7.7
22
57
SPAT1301
SPAT
No procedures
1.3
7.7
810
6738
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
3.4
7.7
26
76
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.4
7.7
49
204
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.1
7.6
68
326
C95.9
ICD-10 Finland
Leukaemia, unspecified
18.4
7.6
11
6
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
18.4
7.6
11
6
L95.8
ICD-10 Finland
Other vasculitis limited to skin
8.0
7.6
16
20
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
25.1
7.6
10
*
AA1
HP
Conventional CABG
2.2
7.5
58
262
N30.0
ICD-10 Finland
Acute cystitis
1.4
7.5
412
3127
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
6.2
7.5
19
31
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
3.8
7.5
22
58
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
7.5
129
768
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.4
544
4310
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
7.4
107
605
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
7.4
70
343
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.8
7.4
35
125
M05BX04
ATC
denosumab; parenteral
1.6
7.4
159
1002
I85
ICD-10 Finland
Oesophageal varices
80.3
7.4
8
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
3.5
7.4
24
68
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.2
7.4
60
277
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
7.4
474
3685
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
3.4
7.4
25
73
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
7.4
304
2199
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
7.7
7.4
16
21
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
7.4
657
5346
ZXA00
NOMESCO Finland
Right side
1.3
7.4
670
5466
S16
ICPC
Bruise/contusion
1.9
7.4
84
441
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.6
7.3
41
160
J47
ICD-10 Finland
Bronchiectasis
2.3
7.3
55
246
E87.6
ICD-10 Finland
Hypokalaemia
1.8
7.3
96
528
28799
ICD-8 Finland
Purpura and other haemorrhagic conditions, Other and unspecified
+∞
7.3
7
*
B72
ICPC
Hodgkin Lymphoma
10.9
7.3
13
12
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
7.3
1072
9255
Z00.8
ICD-10 Finland
Other general examinations
1.5
7.3
194
1287
N17.8
ICD-10 Finland
Other acute renal failure
2.6
7.3
40
155
D97
ICPC
Liver disease NOS
4.1
7.3
19
46
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.2
7.3
28
89
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.1
7.2
65
313
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
7.2
212
1438
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.5
7.2
43
174
B83
ICPC
Purpura/coagulation defect
30.1
7.1
9
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.9
7.1
87
467
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.4
7.1
25
75
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
4.1
7.1
19
47
Z01.7
ICD-10 Finland
Laboratory examination
1.4
7.1
412
3157
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.0
313
2295
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
7.0
179
1175
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
8.8
7.0
14
16
J12.8
ICD-10 Finland
Other viral pneumonia
3.0
7.0
29
96
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
1.9
7.0
80
420
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.2
7.0
59
277
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
7.0
164
1057
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
7.0
7.0
16
23
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
7.0
629
5122
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
7.0
74
379
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.3
7.0
48
207
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.6
7.0
37
141
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.0
7.0
69
345
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.9
7.0
86
464
A11CC03
ATC
alfacalcidol; systemic
2.0
6.9
68
339
D70.81
ICD-10 Finland
Neutropenia congenital
13.8
6.9
11
8
A02BA03
ATC
famotidine; systemic
1.8
6.9
95
531
WF003
NOMESCO Finland
Adjuvant radiotherapy
1.9
6.9
84
452
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
1.7
6.9
121
726
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
10.9
6.8
12
11
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
2.4
6.8
45
191
L01XX52
ATC
venetoclax; oral
9.3
6.8
13
14
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
6.1
6.8
17
28
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.1
6.8
63
308
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
6.8
217
1498
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
6.7
411
3170
A07AA02
ATC
nystatin; oral
1.6
6.7
141
885
C07AA05
ATC
propranolol; systemic
1.3
6.7
461
3619
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.7
348
2619
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
22.6
6.7
9
*
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
2.4
6.6
45
193
JAH01
NOMESCO Finland
Laparoscopy
1.8
6.6
99
567
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.2
6.6
50
225
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1.7
6.6
107
628
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.2
6.6
55
258
C08CA05
ATC
nifedipine; systemic
1.6
6.6
152
977
K83.0
ICD-10 Finland
Cholangitis
2.3
6.6
45
194
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.6
6.5
134
836
RK110, ,
NOMESCO Finland
3.4
6.5
23
69
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
3.0
6.5
28
95
SPAT1229
SPAT
Assessment of need for aid
1.5
6.5
193
1310
RD210, ,
NOMESCO Finland
2.2
6.5
49
220
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.5
6.5
40
164
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
6.5
131
815
R05
ICD-10 Finland
Cough
1.3
6.5
536
4314
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.1
6.5
26
85
C83.71
ICD-10 Finland
Burkitt's tumour
70.0
6.4
7
*
D59.5
ICD-10 Finland
Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
70.0
6.4
7
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
3.4
6.4
22
65
N05BA06
ATC
lorazepam; systemic, sublingual
1.6
6.4
130
810
B81
ICPC
Anaemia vit B12/folate deficiency
1.7
6.4
100
581
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.4
6.4
42
178
SPAT1260
SPAT
Consultation of another employee
1.3
6.4
427
3339
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
6.4
262
1896
SPAT1211
SPAT
Application of soft bandage
1.5
6.3
218
1529
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
2.5
6.3
37
149
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
18.0
6.3
9
5
D65
ICD-10 Finland
Disseminated intravascular coagulation [defibrination syndrome]
+∞
6.2
6
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
26.7
6.2
8
*
D02AX
ATC
Other emollients and protectives
1.9
6.2
74
395
J96.0
ICD-10 Finland
Acute respiratory failure
2.4
6.2
40
168
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.6
6.2
35
138
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.6
6.2
130
817
XX9XE
NOMESCO Finland
Other ultrasound examination
3.1
6.2
24
77
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.3
6.2
42
181
L01BA01
ATC
methotrexate; systemic
1.8
6.1
84
469
WF099
NOMESCO Finland
Other radiotherapy
3.4
6.1
21
62
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
6.1
113
687
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
2.8
6.1
28
99
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.7
6.1
31
116
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.6
6.1
138
884
R4180
NOMESCO Finland
Podiatric therapy
2.4
6.0
38
158
M32
ICD-10 Finland
Systemic lupus erythematosus
10.0
6.0
11
11
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.4
6.0
225
1600
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
1.9
6.0
70
371
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.5
6.0
37
152
RS220, ,
NOMESCO Finland
2.5
6.0
37
152
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
1.9
6.0
67
350
J94.8
ICD-10 Finland
Other specified pleural conditions
2.2
6.0
45
202
A04
ICPC
Weakness/tiredness general
1.3
6.0
405
3169
H26.3
ICD-10 Finland
Drug-induced cataract
3.5
6.0
20
58
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
5.2
6.0
17
33

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Proper column names.
  • Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV not working.
  • No filters and sorters.
  • Limited amount of endpoints with TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Secondary thrombocytopenia
D69.5 (45532995)
Idiopathic thrombocytopenic purpura
D69.3 (45537929)
Hypersplenism
D73.1 (45595776)
Other primary thrombocytopenia
D69.4 (45537930)
Haemorrhagic condition, unspecified
D69.9 (45552362)
Idiopathic thrombocytopaenia or granulocytopenia
129 (2001600127)
Platelet Ab [Presence] in Serum
24375-8 (3018291)
Heparin induced platelet Ab [Units/volume] in Serum
45155-9 (3043870)
Other specified coagulation defects
D68.8 (45532994)
Splenomegaly, not elsewhere classified
R16.1 (45539322)
Collection of stem cells for transplant
YNB10 (2001311211)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 (2002330114)
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 (2002330116)
eltrombopag; oral
B02BX05 (21601076)
Bone marrow aspirate examination
391426006 (4212803)
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
O99.1 (45563195)
Thrombocytopenia, unspecified
D69.6 (45581327)
Transabdominal total splenectomy
JMA10 (2001305478)
Prevention and treatment of malnutrition
OAB73 (2001308651)
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 (2001309601)
Implantation of vascular injection port
TPX10 (2001309608)
Transfer of autologic stem cells
WW300 (2001310591)
Profylactive therapy of malignancy with biomoidiers
WE300 (2001310697)
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
JN5JR (2001310931)
CT of torso and neck
JN6AD (2001310938)
Biopsy of other inner organ with radiological guidance guidance
XW4XT (2001311100)
Social worker
Z2446 (2001311559)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
Karyotype in Bone marrow
81861-7 (21494434)
romiplostim; parenteral
B02BX04 (21601075)
Parvovirus B19 IgG Ab [Titer] in Serum
25630-5 (3009550)
Pathologist interpretation of Cerebral spinal fluid tests
21024-5 (3012320)
Leukocytes other/Leukocytes in Blood
26471-3 (3013727)
TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
21753-9 (3017962)
Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20444-6 (3028369)
Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
50659-2 (3029715)
Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
40724-7 (3040363)
Bone marrow Pathology biopsy report
33721-2 (3045142)
Bone marrow aspiration report
48807-2 (3048879)
Chromosome analysis panel by Banding
62355-3 (40765096)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
71668-8 (43055361)
Myelodysplastic syndrome, NOS, of bone marrow
9989/3-C42.1 (44502674)
Thrombotic microangiopathy
M31.1 (45533824)
Spontaneous ecchymoses
R23.3 (45539326)
Nodular sclerosis classical Hodgkin lymphoma
C81.1 (45547530)
Qualitative platelet defects
D69.1 (45566708)
Refractory anaemia with excess of blasts [RAEB]
D46.2 (45586109)
Other myelodysplastic syndromes
D46.7 (45595762)
Diffuse large B-cell lymphoma
C83.3 (45600549)
Acute leukaemia of unspecified cell type
C95.0 (45600572)
Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
75515-7 (46235128)
Gas panel - Central venous blood
97535-9 (1616796)
Purpura and other haemorrhagic conditions, Thrombocytopenia NUD
28719 (2000301655)
Purpura and other haemorrhagic conditions, Thrombocytopenia, unspecified
2875A (2000402686)
Serous epithelial malignant tumor of the ovary
C56.71 (2000501075)
Drug-induced neutropenia
D70.82 (2000501376)
Familial hypercholesterolaemia
E78.00 (2000501513)
Acute subendocardial infarction unspecified coronary artery status
I21.49 (2000502437)
Extensive MRI examination of brain with high intensity magnet
AA1CG (2001300116)
Very extensive MRI examination of brain with high intensity magnet
AA1DG (2001300120)
Paranasal sinuses X-ray examination in one projection
DM1QA (2001301761)
Mandibular X-ray examination
ED1AA (2001301991)
Neck ultrasound examination
EP1AE (2001302284)
Extensive CT examination of arteria pulmonalis
FB1BD (2001302407)
Standard cardiac ultrasound examination
FM1AE (2001303278)
Doppler ultrasound examination of heart
FM1DE (2001303299)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 (2001304788)
Abdominal ultrasound examination
JN3AE (2001305555)
Urinary tract ultrasound examination
KH1AE (2001306329)
Exploration of soft tissue of pelvis, percutaneous
NEA10 (2001307877)
Drill biopsy of bone marrow, pelvis
TNE25 (2001307884)
Ultrasound examination of upper extremity veins
PH1AE (2001309445)
Ultrasound examination of lower leg veins
PH2AE (2001309451)
Insertion of central venous catheter through external or internal jugular vein
TPH15 (2001309600)
Cathetrisation of artery
TPH07 (2001309747)
Blood transfusion
WW500 (2001310603)
Bone marrow biopsy
XW000 (2001310618)
Demanding cystostatic therapy of methastized malignancy
WD135 (2001310681)
Simple therapy of methastized malignancy with biomodifiers
WD305 (2001310685)
Simple antiboidy therapy of methastized malignancy
WD405 (2001310688)
Sedation and analgesia
WX002 (2001310758)
Intravenous general anesthesia
WX404 (2001310807)
Intensive care
WX872 (2001310844)
Monitored bed care
WX892 (2001310850)
Multidisciplinary treatment meeting
WZC20 (2001310890)
Body CT examination
JN4AD (2001310897)
Very extensive body CT
JN4CD (2001310902)
Whole body extensive metabolic PET with CT
JN4JR (2001310913)
Extensive CT of torso and neck
JN6BD (2001310939)
Excision of bone marrow for transplantation
YNB00 (2001311209)
One hour or less
ZXE00 (2001311394)
More than one and less than three hours
ZXE10 (2001311401)
Subcutaneous
ZX112 (2001311492)
Physiotherapist
Z3226 (2001311560)
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 (2001600117)
Aplastic anaemia
122 (2001600121)
Gout
212 (2001600208)
Abnormal result investigation NOS
A91 (2002000224)
Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
82134-8 (21493195)
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 (21493690)
esomeprazole; oral, parenteral
A02BC05 (21600100)
cyclophosphamide
L01AA01 (21601390)
mercaptopurine
L01BB02 (21601428)
mycophenolic acid; oral, parenteral
L04AA06 (21603896)
oxycodone; oral, parenteral
N02AA05 (21604260)
oxycodone and naloxone; oral
N02AA55 (21604265)
Reticulocyte production index
31111-8 (3000012)
B lymphocytes [#/volume] in Blood
11130-2 (3000060)
Morphology [Interpretation] in Blood Narrative
18314-5 (3000093)
Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
30076-4 (3000108)
Gas panel - Venous blood
24339-4 (3000991)
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 (3001334)
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 (3002482)
Band form neutrophils/Leukocytes in Blood
26508-2 (3004809)
Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
30075-6 (3005156)
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
3193-0 (3005757)
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 (3005895)
Hemoglobin [Mass/volume] in Capillary blood
30352-9 (3006184)
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 (3006217)
CD3-CD19+ cells/cells in Blood
15196-9 (3006245)
Hepatitis E virus Ab [Presence] in Serum
13294-4 (3006922)
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 (3007080)
CD3+CD8+ (T8 suppressor) cells/cells in Blood
8101-8 (3007449)
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 (3007628)
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 (3007844)
Aspergillus sp Ab [Presence] in Serum
7808-9 (3008536)
Leukocyte morphology finding [Identifier] in Blood
11156-7 (3008757)
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 (3009035)
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 (3009041)
Proteinase 3 Ab [Units/volume] in Serum
6968-2 (3009445)
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 (3009595)
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 (3010130)
pH of Blood
11558-4 (3010421)
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 (3010517)
Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11483-5 (3012202)
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 (3012477)
Base excess in Blood by calculation
11555-0 (3012501)
Helicobacter pylori Ag [Presence] in Stool
31843-6 (3013139)
Carbon dioxide [Partial pressure] in Blood
11557-6 (3013290)
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 (3013327)
Fractional oxyhemoglobin in Arterial blood
2714-4 (3014007)
Lactate [Moles/volume] in Serum or Plasma
2524-7 (3014111)
Chloride [Moles/volume] in Serum or Plasma
2075-0 (3014576)
Toxoplasma gondii IgG Ab [Units/volume] in Serum
8039-0 (3014959)
Extractable nuclear Ab [Units/volume] in Serum
30342-0 (3015171)
Bicarbonate [Moles/volume] in Capillary blood
1961-2 (3015235)
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 (3015635)
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 (3016407)
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
2532-0 (3016436)
Methotrexate [Moles/volume] in Serum or Plasma
14836-1 (3017115)
Hepatitis C virus Ab [Presence] in Serum
16128-1 (3017143)
Segmented neutrophils/Leukocytes in Blood
26505-8 (3017354)
Neutrophils [#/volume] in Blood
26499-4 (3017732)
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 (3017895)
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 (3017918)
Lactate [Moles/volume] in Arterial blood
2518-9 (3018405)
Toxoplasma gondii IgA Ab [Units/volume] in Serum
22578-9 (3018921)
Gas panel - Arterial blood
24336-0 (3019060)
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 (3019250)
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 (3019284)
Blood group antibody investigation [Interpretation] in Plasma or RBC
14575-5 (3019601)
Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5000-5 (3020229)
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 (3020427)
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 (3020565)
Body temperature
8310-5 (3020891)
Hepatitis B virus core Ab [Presence] in Serum
16933-4 (3021879)
Oxygen saturation in Capillary blood
2709-4 (3021901)
Free Hemoglobin [Mass/volume] in Plasma
721-1 (3022493)
Fractional oxyhemoglobin in Capillary blood
2715-1 (3022806)
Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
1007-4 (3022907)
Ammonium ion [Moles/volume] in Plasma
1845-7 (3023183)
Erythropoietin (EPO) [Units/volume] in Serum or Plasma
15061-5 (3024172)
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 (3024403)
HLA-A [Type]
13298-5 (3024471)
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 (3024889)
HLA-DR beta [Type]
13306-6 (3024932)
Oxygen [Partial pressure] in Blood
11556-8 (3027315)
Toxoplasma gondii IgM Ab [Units/volume] in Serum
8040-8 (3027529)
Lactate [Moles/volume] in Capillary blood
19239-3 (3028271)
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 (3029080)
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 (3030692)
Hyaline casts [#/volume] in Urine by Automated count
51484-4 (3030981)
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 (3031478)
Blasts [#/volume] in Cerebral spinal fluid
35068-6 (3032352)
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49672-9 (3032699)
Glomerular basement membrane Ab [Units/volume] in Serum
49774-3 (3032700)
Lactate [Moles/volume] in Cerebral spinal fluid
2520-5 (3035999)
Cortisol [Moles/volume] in Serum or Plasma
14675-3 (3036481)
Nuclear Ab [Titer] in Serum
29953-7 (3037522)
Legionella sp identified in Specimen by Organism specific culture
593-4 (3037692)
Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29723-4 (3037875)
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 (3040853)
Morphology [Interpretation] in Bone marrow Narrative
51628-6 (3042111)
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 (3042194)
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 (3042596)
Mycobacterium sp identified in Specimen
40699-1 (3042631)
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 (3043849)
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 (3044254)
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44448-9 (3044355)
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 (3046279)
Epstein Barr virus Ab [Presence] in Serum
49178-7 (3048929)
Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
48674-6 (3049539)
HTLV I+II Ab panel - Serum
55162-2 (40758292)
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
55774-4 (40758895)
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
55776-9 (40758897)
Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
56990-5 (40760109)
Immunoglobulin light chains.free panel - Serum
57778-3 (40760888)
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 (40762119)
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 (40764126)
Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61366-1 (40764127)
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 (40765161)
Oxygen content in Capillary blood by calculation
64799-0 (40767503)
Lymph node Pathology biopsy report
66112-4 (40768795)
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
68324-3 (40770918)
Neutrophil count
30630007 (4148615)
Lupus anticoagulant assay
63300003 (4268621)
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
70058-3 (42868544)
Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
72103-5 (42869858)
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 (43055120)
Diffuse large B-cell lymphoma, NOS, of brain, NOS
9680/3-C71.9 (44501321)
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
9811/3-C42.1 (44501999)
Mantle cell lymphoma of bone marrow
9673/3-C42.1 (44502849)
Acute myeloid leukemia, NOS, of bone marrow
9861/3-C42.1 (44504699)
Sepsis due to Staphylococcus aureus
A41.0 (45532832)
Haemorrhagic fever with renal syndrome
A98.5 (45532861)
Follicular lymphoma grade II
C82.1 (45532946)
Other obesity
E66.8 (45533036)
Acute lymphoblastic leukaemia [ALL]
C91.0 (45537873)
Hyperlipidaemia, unspecified
E78.5 (45537986)
Hypokalaemia
E87.6 (45537991)
Other and unspecified cirrhosis of liver
K74.6 (45538546)
Mantle cell lymphoma
C83.1 (45542646)
Hypo-osmolality and hyponatraemia
E87.1 (45542779)
Interstitial pulmonary disease, unspecified
J84.9 (45543277)
Routine postpartum follow-up
Z39.2 (45547306)
Ascites
R18 (45548949)
Observation for suspected disease or condition, unspecified
Z03.9 (45552062)
Enterocolitis due to Clostridium difficile
A04.7 (45552153)
Venous insufficiency (chronic)(peripheral)
I87.2 (45552867)
Sepsis due to other Gram-negative organisms
A41.5 (45556902)
Myelodysplastic syndrome, unspecified
D46.9 (45557083)
Other specified disorders of white blood cells
D72.8 (45561931)
Presence of electronic cardiac devices
Z95.0 (45571406)
Chronic atrial fibrillation
I48.2 (45591467)
Haemorrhage of anus and rectum
K62.5 (45596339)
Alcoholic cirrhosis of liver
K70.3 (45596343)
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 (45599741)
Multiple myeloma
C90.0 (45600562)
Chronic lymphocytic leukaemia of B-cell type
C91.1 (45600564)
Acute myeloblastic leukaemia [AML]
C92.0 (45600565)
Viral infection, unspecified
B34.9 (45605229)
Epistaxis
R04.0 (45606791)
Non-follicular lymphoma
C83 (45755342)
Emergency use of U07.1 | COVID-19, virus identified
U07.1 (45756093)
Maternal and Fetal Medicine
OMOP4821963 (45756780)
Pediatric Hematology-Oncology
OMOP4822028 (45756811)
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 (46235759)
Reticulocytes/Erythrocytes in Blood
4679-7 (3027945)
Diffuse lymphoma with large B cells
C83.31 (2000501224)
filgrastim; parenteral
L03AA02 (21603851)
Demanding cystostatic therapy of methastized malignancy
WD125 (2001310680)
Hematology
82 (38004501)
pegfilgrastim; parenteral
L03AA13 (21603856)
lipegfilgrastim; parenteral
L03AA14 (43534819)
sulfamethoxazole and trimethoprim
J01EE01 (21602961)
Granulocytes/Leukocytes in Blood
30395-8 (3035933)
Reticulocytes [#/volume] in Blood
14196-0 (3023520)
IgM [Mass/volume] in Serum or Plasma
2472-9 (3028026)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
Differential panel, method unspecified - Blood
69738-3 (42870588)
Chemotherapy session for neoplasm
Z51.1 (45595526)
Internal Medicine
11 (38004456)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
IgA [Mass/volume] in Serum or Plasma
2458-8 (3007164)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
Basophils/Leukocytes in Blood
30180-4 (3022096)
granisetron; oral, parenteral, transdermal
A04AA02 (21600494)
Medical Oncology
90 (38004507)
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 (3012336)
Cystostatic therapy of methastized malignancy
WD105 (2001310678)
IgG [Mass/volume] in Serum or Plasma
2465-3 (3005719)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 (3022250)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
CD3 cells/Lymphocytes in Blood
90304-7 (1175426)
Monocytes [#/volume] in Blood
26484-6 (3001604)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
Basophils [#/volume] in Blood
26444-0 (3006315)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
Demanding antibody therapy of methastized malignancy
WD415 (2001310689)
Thorax X-ray examination
GD1AA (2001303617)
Anaemia, unspecified
D64.9 (45600610)
CD3 cells [#/volume] in Blood
8122-4 (3011412)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
pH of Serum or Plasma
2753-2 (3018418)
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 (3000515)
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 (46237023)
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20607-8 (3020073)
CD4 cells/Lymphocytes in Specimen
80223-1 (21494815)
Inpatient Hospital
21 (8717)
Immunohistochemistry procedure
117617002 (4035726)
Myelocytes/Leukocytes in Blood
26498-6 (3017181)
Outpatient Hospital
22 (8756)
CD8 cells/Lymphocytes in Specimen
80222-3 (21494814)
CD19 cells/cells in Blood
8117-4 (3016228)
Metamyelocytes/Leukocytes in Blood
28541-1 (3002179)
Protein electrophoresis panel - Serum or Plasma
24351-9 (3004588)
Emergency Room Visit
ER (9203)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
Extensive body CT
JN4BD (2001310899)
Bacterial infection, unspecified
A49.9 (45590816)
Promyelocytes/Leukocytes in Blood
26524-9 (3021440)
Thrombin time
3243-3 (3036489)
HIV 1 and 2 tests - Meaningful Use set
75622-1 (46235355)
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 (3029379)
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 (3029338)
Normoblasts [#/volume] in Blood
715-3 (3021589)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 (3048816)
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 (3035797)
Blasts/Leukocytes in Blood
26446-5 (3025159)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
Multiple cystostatic therapy of methastized malignancy
WD115 (2001310679)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 (36305247)
ondansetron; oral, parenteral, rectal
A04AA01 (21600493)
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 (3007778)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 (3023465)
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 (3047169)
Magnesium [Moles/volume] in Serum or Plasma
2601-3 (3012095)
Kappa light chains.free [Mass/volume] in Serum
36916-5 (3034860)
Protein [Mass/volume] in Serum or Plasma
2885-2 (3020630)
Osmolality of Urine
2695-5 (3026782)
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 (3043747)
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 (3043723)
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 (3005229)
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 (3029713)
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 (3015322)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
Intravenous
ZX120 (2001311495)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
B-cell lymphoma in marginal zone
C83.80 (2000501237)
Hemodialysis
TK800 (2001305768)
Acute renal failure, unspecified
N17.9 (45567829)
Erythrocytes [Presence] in Urine by Automated
53292-9 (3041096)
CD19 cells [#/volume] in Blood
8116-6 (3010503)
Granulocytes [#/volume] in Blood
30394-1 (3035715)
Casts [#/volume] in Urine by Automated count
51483-6 (3030467)
Erythrocytes [#/volume] in Urine
30391-7 (3002582)
Bacteria [Presence] in Urine
87829-8 (36304419)
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 (3027831)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 (3015399)
darbepoetin alfa; parenteral
B03XA02 (21601134)
High resolution CT examination of lungs
GD1DD (2001303632)
Ultrasound examination of upper part of abdomen
JN1AE (2001305517)
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 (3027475)
Sepsis, unspecified
A41.9 (45585911)
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 (3016543)
Short blood count panel - Blood
55429-5 (40758558)
Ferritin [Mass/volume] in Serum or Plasma
2276-4 (3001122)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 (43054903)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
Fever, unspecified
R50.9 (45582716)
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 (3014162)
DNA double strand Ab [Units/volume] in Serum
5130-0 (3023420)
palonosetron, combinations
A04AA55 (45893275)
Emergency Medicine
93 (38004510)
Cell count panel - Cerebral spinal fluid
34563-7 (3044290)
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 (3051552)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
Albumin [Presence] in Urine by Test strip
50949-7 (3029937)
Immunofixation for Serum or Plasma
25700-6 (3037756)
Supplier / Service Provider
OMOP5117446 (33004)
Microorganisms panel - Urine sediment
58435-9 (40761536)
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 (3019473)
tinzaparin; parenteral
B01AB10 (21600981)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
General Practice
1 (38004446)
Glucose [Presence] in Urine by Test strip
25428-4 (3009261)
Nitrite [Presence] in Urine by Test strip
5802-4 (3021601)
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 (3013742)
Ketones [Presence] in Urine by Test strip
2514-8 (3035350)
Oesophageal varices without bleeding
I85.9 (45581834)
INR in Blood by Coagulation assay
34714-6 (3032080)
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 (40763086)
prednisolone; oral, parenteral
H02AB06 (21602734)
prednisolone
A07EA01 (21600653)
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 (3005772)
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 (3038288)
dexamethasone; oral, parenteral
H02AB02 (21602730)
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 (3043924)
Other transplanted organ and tissue status
Z94.8 (45600381)
Metastasis
OMOP4998856 (36769180)
Secondary malignant neoplasm of other specified sites
C79.8 (45547524)
Chronic kidney disease, unspecified
N18.9 (45553438)
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 (3012110)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
moxifloxacin; oral, parenteral
J01MA14 (21603021)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 (3005702)
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 (40763571)
Bacteria identified in Urine by Culture
630-4 (3026008)
Biopsy of lymphnode with ultrasound guidance
PJ2AT (2001309679)
levofloxacin; inhalant, oral, parenteral
J01MA12 (21603019)
Bacteria identified in Blood by Culture
600-7 (3023368)
tranexamic acid; oral, parenteral
B02AA02 (21601036)
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 (3016921)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
Transferrin [Mass/volume] in Serum or Plasma
3034-6 (3004789)
metoclopramide; oral, parenteral, rectal
A03FA01 (21600484)
Multiple adjuvant cytostatic therapy
WB113 (2001310629)
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 (3027450)
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 (3006999)
Iron [Moles/volume] in Serum or Plasma
14798-3 (3022948)
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 (3014037)
Radiotherapy of metastasis
WF049 (2001310705)
pH of Urine
2756-5 (3015736)
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 (586526)
Metastasis to intrahepatic bile ducts
OMOP5031661 (35226180)
Metastasis to liver
OMOP5000224 (36770544)
Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.7 (45595688)
Phosphatidylethanol [Mass/volume] in Blood
74661-0 (44816559)
Outpatient Visit
OP (9202)
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 (3001405)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
Excision of cervical lymph nodes
PJD41 (2001309632)
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 (21492711)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
Treponema pallidum Ab [Presence] in Serum
22587-0 (3019832)
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 (3025271)
Infectious Disease
44 (38004484)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
Platelets [#/volume] in Blood
26515-7 (3007461)
prednisone
A07EA03 (21600655)
prednisone; oral
H02AB07 (21602735)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
MCH [Entitic mass]
28539-5 (3035941)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
Oncology Clinic/Center
261QX0200X (38004268)
Melaena
K92.1 (45533624)
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 (3028167)
ursodeoxycholic acid; oral
A05AA02 (21600513)
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 (42529201)
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 (3016293)
Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9654-5 (3007847)
CBC panel - Blood by Automated count
58410-2 (40761511)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 (3007220)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
Atrial fibrillation and flutter
I48 (45596206)
Extensive abdominal CT
JN3BD (2001305556)
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
54218-3 (40757349)
Folate [Moles/volume] in Red Blood Cells
14731-4 (3019309)
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 (3030366)
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1952-1 (3013201)
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 (3051714)
Nephrology
39 (38004479)
Treatment plan or consultation
WZC00 (2001310885)
Folate [Moles/volume] in Serum or Plasma
14732-2 (3021960)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
Urate [Moles/volume] in Serum or Plasma
14933-6 (3026493)
nystatin; oral
A07AA02 (21600604)
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 (3034780)
Blood chemistry outside reference range
166318006 (436230)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
Iron deficiency anaemia, unspecified
D50.9 (45605373)
Type 2 diabetes mellitus, without complications
E11.9 (45561952)
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 (3017766)
Inpatient Visit
IP (9201)
Blood group antibody screen [Presence] in Serum or Plasma
890-4 (3001079)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
Hypothyroidism, unspecified
E03.9 (45537945)
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 (3008909)
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 (3000620)
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 (706163)
Oral Surgery
19 (38004464)
More than three and less than five hours
ZXE20 (2001311408)
Oxygen [Partial pressure] in Capillary blood
2704-5 (3028626)
Atherosclerotic heart disease
I25.1 (45596196)
Obstetrics / Gynecology
16 (38004461)
ABO and Rh group [Type] in Blood
882-1 (3003694)
Bacteria identified in Stool by Culture
625-4 (3025941)
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 (36031861)
capecitabine
L01BC06 (21601440)

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
548
795
8.17
307.65
3.5
2.6
3.33
3.61
g/l
3.37
527
756
1017
2874
4.79
307.65
1.7
1.6
—
—
—
0
0
791
438
23.97
307.65
2.0
1.5
—
—
—
0
0
1252
2669
7.23
307.65
5.2
2.6
76.43
68.96
e9/l
3.90
949
1963
981
2106
6.37
307.65
3.9
2.8
10.10
10.66
g/l
2.37
931
1935
429
259
19.09
307.65
1.2
1.1
—
—
—
0
0
802
1911
5.33
307.65
1.5
1.5
—
—
—
0
0
510
298
20.32
307.65
1.7
1.3
—
—
—
0
0
1480
3435
7.38
307.65
5.1
2.6
1.96
1.78
%
5.82
1397
3063
433
230
21.75
307.65
1.3
1.2
—
—
—
0
0
730
1378
6.64
307.65
2.5
1.8
1.19
1.53
g/l
14.83
625
1199
850
1661
6.69
307.65
2.2
1.9
1.22
1.36
g/l
0.93
806
1523
1972
9438
4.04
305.05
13.7
6.2
—
—
—
0
0
1122
3777
4.10
288.35
1.8
1.7
—
—
—
0
0
2307
12867
4.19
271.69
15.0
6.5
9.85
8.96
%
16.92
2242
12052
1193
4365
3.83
268.79
3.5
2.0
30.27
29.65
s
2.46
1164
4243
2298
12846
4.13
268.15
14.8
6.4
2.36
2.84
%
23.19
2237
12021
2320
13120
4.14
264.43
14.9
6.5
27.60
27.27
%
0.57
2269
12435
2283
12852
4.02
260.02
15.0
6.5
0.61
0.67
%
4.45
2226
12025
264
246
11.65
248.21
3.4
2.3
1005.94
1209.38
e6/l
2.05
228
213
835
2507
4.20
247.28
8.3
4.3
0.98
0.88
%
0.53
564
753
234
181
13.91
247.26
2.8
2.4
14.88
15.12
%
0.09
228
175
238
193
13.28
244.44
2.9
2.3
74.33
73.47
%
0.26
230
179
2252
12872
3.81
243.22
13.9
6.3
56.21
57.61
%
4.90
2207
12289
328
424
8.54
241.54
3.6
2.1
1.00
0.91
%
1.34
272
293
2355
13911
3.97
240.45
13.8
6.2
0.58
0.60
e9/l
1.76
2136
11840
1214
4776
3.55
240.14
7.9
3.5
0.79
0.82
mmol/l
8.57
1168
4510
2355
13943
3.95
238.83
13.7
6.2
0.03
0.04
e9/l
26.70
2133
11865
2394
14366
4.02
236.92
14.8
6.4
0.15
0.19
e9/l
40.38
2185
12426
2373
14207
3.95
234.48
14.0
6.3
1.62
1.91
e9/l
13.48
2188
12399
796
2397
4.13
233.52
8.2
4.1
0.85
0.71
%
1.06
534
722
1156
4498
3.52
231.21
1.9
1.9
—
—
—
0
0
806
2478
4.05
229.31
2.9
2.7
65.30
66.39
g/l
2.78
763
2285
326
473
7.59
216.91
6.4
3.4
1.51
1.55
%
0.06
300
421
775
2408
3.97
216.02
8.4
4.3
0.18
0.11
%
1.99
500
655
1086
4272
3.39
210.22
3.4
2.7
26.37
22.59
%
6.98
1046
3984
2448
15582
3.81
205.72
25.9
9.3
3.54
4.19
e9/l
26.68
2260
13444
2322
14426
3.50
200.08
16.2
6.6
14.50
12.14
umol/l
6.53
2267
13784
1120
4612
3.25
199.20
3.4
2.7
2.20
2.29
g/l
5.33
1064
4264
752
2433
3.77
195.89
8.9
4.5
0.93
0.09
%
2.29
476
618
1162
4942
3.17
194.82
3.4
2.7
13.90
12.87
umol/l
3.12
1121
4612
161
97
17.46
194.28
2.6
2.1
40.09
28.71
%
7.74
161
97
326
533
6.72
193.65
1.4
1.5
—
—
—
0
0
1592
8110
3.00
192.74
9.1
4.4
—
—
—
0
0
296
480
6.72
176.89
1.4
1.5
139.31
144.38
au/ml
0.23
88
153
974
3945
3.15
174.67
9.8
6.3
1.06
1.05
mmol/l
0.75
930
3682
2043
12446
2.92
168.50
9.7
5.2
33.80
35.44
g/l
27.22
1962
11678
1164
5334
2.90
165.72
2.2
1.5
2.63
2.49
g/l
0.91
919
3245
679
2328
3.46
158.91
1.8
1.4
—
—
—
0
0
289
513
6.11
157.47
1.3
1.3
284.76
251.87
u/ml
0.79
187
292
1536
8350
2.68
153.80
8.9
4.2
7.40
7.40
ph
7.58
1202
6038
875
3563
3.04
152.70
1.6
1.3
673.93
491.63
titre
1.59
224
777
745
2775
3.22
151.62
3.3
2.3
0.19
0.21
g/l
10.36
698
2585
401
994
4.49
148.63
3.3
2.2
21.81
21.20
s
1.05
379
893
363
840
4.77
146.60
1.3
1.3
—
—
—
0
0
1339
6973
2.63
143.88
8.2
4.2
81.89
87.61
%
12.23
1302
6827
1993
12609
2.65
141.59
13.2
7.1
1.20
1.21
mmol/l
5.24
1899
11639
1187
5912
2.64
138.66
10.9
4.6
—
—
—
0
0
2130
14044
2.69
136.82
14.6
7.7
1.20
1.21
mmol/l
4.52
1782
12125
389
1013
4.25
134.70
3.0
3.5
35.58
73.75
mg/l
1.66
311
862
389
1014
4.25
134.51
3.0
3.5
180.60
55.38
mg/l
0.47
311
862
1373
7613
2.45
124.38
3.0
2.3
3.22
2.81
mg/l
5.61
1254
6554
760
3173
2.85
123.59
5.8
2.8
12.68
8.52
umol/l
3.23
684
2809
352
907
4.25
123.25
2.8
3.3
11.03
3.02
ratio
0.63
171
526
1985
13034
2.48
122.13
22.1
16.1
1.31
1.28
inr
1.30
1730
10901
1313
7215
2.43
120.36
5.3
2.9
339.52
349.86
umol/l
2.52
1224
6332
277
604
4.94
119.57
5.6
3.1
56.08
58.01
%
1.27
277
604
285
638
4.82
119.19
5.5
2.7
41.16
36.47
umol/l
1.24
267
573
1866
12027
2.40
118.00
30.2
11.7
0.01
0.00
e9/l
2.14
1577
9747
1425
8188
2.38
117.22
2.1
1.7
18.64
20.09
nmol/l
3.63
1302
6927
414
1258
3.65
114.48
2.4
1.9
2.13
1.99
ug/l
0.08
384
1113
171
245
7.33
114.01
1.6
1.2
—
—
—
0
0
275
621
4.76
113.69
1.6
1.6
—
—
—
0
0
225
432
5.54
112.16
1.1
1.1
—
—
—
0
0
1501
8972
2.32
110.74
6.0
2.5
—
—
—
0
0
672
2778
2.82
110.04
11.5
7.4
11.04
10.27
mmol/l
1.53
646
2660
219
418
5.56
109.84
1.1
1.1
—
—
—
0
0
397
1206
3.63
109.63
2.1
2.4
6.60
7.43
g/l
16.95
370
1110
397
1206
3.63
109.63
2.1
2.4
4.07
4.18
g/l
1.36
370
1111
396
1205
3.62
109.05
2.1
2.4
3.62
3.76
g/l
0.55
369
1110
1895
12550
2.33
108.76
4.6
3.1
331.89
130.69
ug/l
14.11
1808
11676
298
770
4.18
103.44
2.7
1.6
0.20
0.24
g/l
8.25
273
739
175
287
6.40
102.64
7.5
3.7
—
—
—
0
0
137
175
8.15
100.80
3.8
2.3
559.86
526.35
e6/l
0.17
90
139
300
795
4.07
100.55
2.7
1.6
1.10
1.19
g/l
4.32
281
761
369
1129
3.58
100.46
2.1
2.5
2.87
2.95
g/l
0.76
342
1034
95
77
12.70
96.90
1.0
1.0
—
—
—
0
0
170
289
6.17
96.14
2.5
2.5
12.30
40.44
iu/ml
2.18
26
36
150
225
6.96
95.77
1.5
1.9
4.51
4.65
mg/l
0.09
142
217
245
586
4.46
93.92
1.2
1.3
—
—
—
0
0
1339
8019
2.19
93.76
4.4
3.5
0.47
0.41
e6/l
0.53
1069
5948
228
520
4.66
92.77
1.5
1.2
109.66
34.04
u/l
5.20
214
449
131
175
7.77
92.75
4.2
2.4
209.40
230.55
e6/l
0.32
94
150
1485
9295
2.16
92.46
4.6
3.6
108.97
82.59
e6/l
0.38
1219
7152
340
1045
3.53
91.63
2.0
2.5
10.69
10.35
g/l
0.56
312
943
1614
10476
2.14
90.91
5.5
4.2
109.24
101.39
e6/l
0.09
1256
7481
1858
12728
2.16
90.89
6.2
2.8
—
—
estimate
—
0
0
543
2211
2.77
90.02
10.8
3.8
1.22
1.23
mmol/l
3.16
505
1909
274
737
3.98
89.72
1.3
1.2
89.29
97.38
titre
0.18
28
65
2594
20511
2.70
88.78
20.5
8.3
88.78
80.71
u/l
9.05
2542
19490
1276
7623
2.15
88.58
4.2
3.4
1.40
79.69
estimate
—
5
32
61
24
25.91
87.69
1.3
1.2
0.13
0.05
u/ml
—
8
6
1054
5873
2.21
87.04
2.7
1.7
1.93
1.30
mg/l
5.75
892
4552
1005
5542
2.21
84.75
3.8
3.0
505.91
538.39
mosm/kgh2o
5.42
931
4866
167
315
5.55
84.60
6.7
3.4
52.45
59.45
%
2.87
151
272
910
4823
2.26
84.58
2.1
1.8
1234.41
1166.25
nmol/l
1.26
734
3652
265
736
3.85
82.79
1.3
1.2
990.00
1179.00
titre
—
8
20
793
4057
2.29
79.54
2.6
2.1
—
—
—
0
0
120
173
7.18
79.37
3.9
2.1
0.50
0.71
e9/l
2.32
110
163
578
2598
2.51
77.49
2.3
2.3
358.61
377.92
nmol/l
1.52
552
2402
168
357
4.92
74.27
1.5
1.2
5.08
3.48
u/ml
0.99
101
164
80
76
10.78
73.54
1.2
1.1
—
—
—
0
0
2159
16307
2.09
73.53
10.4
5.4
6.68
6.77
mmol/l
1.07
2102
15515
1087
6454
2.06
73.43
3.6
2.8
5.80
5.25
e6/l
0.66
1026
5896
78
72
11.09
73.11
2.8
2.5
0.19
0.22
e9/l
0.15
32
30
1755
12344
1.98
72.79
2.7
2.2
91.99
94.73
pmol/l
1.64
1142
6630
88
97
9.31
72.69
1.1
1.1
—
—
—
0
0
282
892
3.38
72.16
7.0
4.8
1.66
1.57
mg/l
0.85
263
808
84
92
9.36
69.71
3.0
2.5
34.69
28.51
%
2.22
78
86
2274
17662
2.11
69.66
6.3
4.9
133.04
1401.58
e6/l
2.98
52
257
1377
9016
1.96
69.35
6.2
3.2
41.09
36.84
u/l
0.90
1309
8522
1339
8700
1.96
68.84
3.8
2.7
56.72
69.59
u/l
0.77
1254
8072
77
79
9.97
67.04
1.0
1.2
904.17
820.00
titre
0.16
24
15
83
97
8.77
65.51
3.0
2.6
10.36
9.40
%
0.24
74
88
82
97
8.66
64.10
1.1
1.1
—
—
—
0
0
226
669
3.57
63.96
4.9
3.9
—
—
—
0
0
485
2184
2.45
63.83
5.9
4.1
—
—
—
0
0
468
2077
2.48
63.56
10.5
9.7
24.13
24.87
mmol/l
4.23
461
2068
301
1069
3.01
63.19
2.7
1.7
9.18
7.46
iu/ml
0.42
75
250
59
45
13.35
62.27
1.4
1.3
—
—
—
0
0
128
257
5.15
60.37
2.6
2.2
—
—
—
0
0
1401
9536
1.86
59.89
5.3
3.5
2.33
2.35
mmol/l
9.02
1307
8673
270
935
3.07
59.15
5.4
3.9
7.42
7.41
ph
3.32
264
927
204
602
3.56
57.93
5.8
4.6
8.70
8.43
kpa
1.31
197
593
203
599
3.56
57.65
5.8
4.6
2.21
2.58
mmol/l
1.11
141
413
203
600
3.55
57.50
5.8
4.6
4.73
5.05
kpa
7.35
196
592
268
940
3.03
57.37
1.5
1.6
27.01
17.72
u/ml
0.69
37
200
1255
8390
1.84
55.64
3.9
3.3
—
—
—
0
0
2391
19517
2.02
55.51
6.8
4.4
16.52
12.43
mm/h
21.57
2281
18217
59
57
10.53
53.55
3.1
1.6
—
—
—
0
0
156
405
4.00
53.28
2.3
2.7
—
—
—
0
0
627
3382
2.07
52.32
5.0
3.3
7.17
4.54
e9/l
2.73
561
2914
93
159
6.00
52.15
3.2
2.7
34.53
40.79
%
1.67
49
89
1860
14162
1.79
51.88
5.3
4.0
0.00
0.00
estimate
0.50
588
3059
1873
14345
1.78
50.62
5.3
4.0
4.20
3.07
estimate
0.14
598
3109
79
118
6.84
50.52
35.0
30.5
137.34
125.61
ug/l
0.62
70
96
436
2072
2.29
49.98
6.3
4.5
5.00
5.14
kpa
2.88
422
1989
1878
14424
1.78
49.95
5.4
4.0
0.01
0.12
estimate
0.52
565
2899
199
641
3.25
49.11
4.5
2.9
89.22
89.65
%
0.32
192
624
1261
8688
1.77
48.69
4.2
3.2
1990.62
1488.14
ng/l
3.33
1140
7517
424
2015
2.28
48.52
6.4
4.6
7.42
7.41
ph
1.05
366
1674
162
461
3.65
48.50
2.7
1.9
1.99
1.71
mmol/l
1.86
156
449
239
873
2.88
47.38
6.1
4.8
8.15
8.31
kpa
0.77
230
855
291
1181
2.62
47.06
1.4
1.5
6.32
18.10
iu/ml
—
6
32
38
22
17.47
46.30
1.1
1.1
—
—
—
0
0
203
686
3.10
46.19
2.0
2.0
11.49
12.04
mg/l
0.36
191
631
149
426
3.62
44.28
7.2
6.4
11.83
12.08
mg/l
0.26
140
400
393
1898
2.23
42.98
7.2
4.2
23.89
24.04
mmol/l
0.40
382
1876
141
397
3.67
42.86
2.0
1.5
—
—
—
0
0
141
397
3.67
42.86
2.0
1.5
—
—
—
0
0
141
397
3.67
42.86
2.0
1.5
—
—
—
0
0
141
397
3.67
42.86
2.0
1.5
—
—
—
0
0
1182
8209
1.71
42.84
14.5
6.2
—
—
—
0
0
577
3234
1.97
42.34
6.8
4.1
7.38
7.38
ph
0.01
358
1883
895
5774
1.78
41.99
1.9
1.8
473.37
29243739.01
pmol/l
4.59
768
4784
570
3202
1.96
41.47
6.7
4.0
5.68
5.82
kpa
3.00
551
3114
71
117
6.19
41.31
2.8
2.4
165.13
60.83
mg/l
0.52
64
87
754
4643
1.83
41.24
4.1
3.3
2.30
1.96
e6/l
0.46
405
2323
555
3105
1.96
40.81
6.8
4.0
1.32
1.77
mmol/l
1.98
486
2667
147
442
3.44
40.45
2.0
1.6
0.68
0.87
g/l
1.08
111
345
57
77
7.52
39.88
1.1
1.1
—
—
—
0
0
245
990
2.60
39.82
1.3
1.2
—
—
—
0
0
498
2717
1.99
39.24
12.2
9.6
—
—
—
0
0
37
28
13.36
39.11
4.1
2.2
—
—
—
0
0
306
1388
2.34
38.68
1.4
1.2
—
—
—
0
0
1099
7642
1.68
38.63
1.8
1.4
—
—
—
0
0
499
2748
1.97
38.20
10.2
8.4
1.53
1.36
mmol/l
1.79
489
2700
111
289
3.95
37.74
1.2
1.1
—
—
—
0
0
1418
10578
1.63
37.48
5.8
4.0
43.09
111.27
ng/l
0.97
1171
7738
235
961
2.56
37.22
1.4
1.2
0.97
0.82
u/ml
—
7
72
1503
11397
1.62
37.00
4.5
3.5
6.21
6.24
ph
0.60
831
6339
571
3322
1.88
36.97
2.0
1.8
—
—
—
0
0
251
1071
2.46
36.32
5.2
3.1
23.98
24.71
mmol/l
1.92
243
1058
563
3299
1.86
35.51
2.1
1.5
—
—
—
0
0
196
762
2.68
34.35
1.4
1.3
21.30
15.15
iu/ml
—
7
13
473
2648
1.93
34.23
3.0
2.5
32.59
57.96
u/l
0.77
393
2221
83
188
4.51
33.91
1.1
1.0
—
—
—
0
0
1116
7993
1.62
33.78
5.6
4.1
0.00
0.00
estimate
1.54
529
2790
101
267
3.88
33.63
1.6
1.3
—
—
—
0
0
615
3761
1.79
33.55
1.3
1.3
—
—
—
0
0
250
1105
2.37
33.41
2.0
1.6
0.37
0.33
mg/l
0.34
110
516
123
373
3.39
33.39
1.2
1.1
1.58
1.51
g/l
0.70
117
343
100
269
3.81
32.49
1.7
1.3
0.46
0.41
g/l
0.41
65
192
100
269
3.81
32.49
1.7
1.3
6.47
6.79
g/l
0.34
66
193
100
269
3.81
32.49
1.7
1.3
2.69
2.94
g/l
0.68
67
193
63
118
5.43
32.11
35.7
38.9
7.10
6.95
ug/l
0.23
58
107
569
3442
1.80
32.05
10.1
8.3
0.66
0.90
mmol/l
0.67
465
2825
81
189
4.37
31.88
2.1
1.4
—
—
—
0
0
825
5541
1.67
31.87
3.8
3.0
2.46
2.45
mmol/l
0.95
750
4982
765
5043
1.69
31.71
3.9
3.2
1.22
1.02
e6/l
0.44
418
2735
570
3473
1.79
31.26
10.3
8.3
7.42
7.41
ph
2.25
311
1897
569
3475
1.78
30.93
10.2
8.3
4.93
5.10
kpa
3.93
546
3337
568
3476
1.78
30.63
10.2
8.3
12.44
12.17
kpa
0.55
544
3341
52
85
6.20
30.52
2.9
1.8
3929.57
22546.88
e6/l
0.45
37
52
180
714
2.62
30.28
3.2
2.3
115.90
129.26
g/l
8.87
155
563
1541
12102
1.55
30.25
3.1
2.5
75.56
77.21
nmol/l
1.51
1419
10872
399
2194
1.94
30.23
1.6
1.8
—
—
—
0
0
464
2686
1.86
30.01
6.0
3.5
4.72
4.59
kpa
0.67
445
2612
338
1759
2.04
29.96
1.2
1.3
—
—
—
0
0
56
101
5.63
29.73
3.1
2.1
436.00
759.89
e6/l
1.08
48
79
1046
7568
1.58
29.32
5.3
3.4
0.01
0.14
estimate
0.67
491
2398
52
89
5.93
29.15
1.9
1.4
9.58
12.64
g/l
1.35
33
68
494
2947
1.81
28.89
4.0
4.3
17.77
22.68
ug/l
0.25
400
2420
1164
8660
1.55
28.70
2.9
2.2
314.51
226.46
u/l
0.53
1106
8211
48
79
6.16
27.99
3.3
1.7
—
—
—
0
0
119
401
3.05
27.17
2.1
2.6
—
—
—
0
0
63
137
4.67
27.09
1.3
1.2
1.14
1.07
ratio
0.95
55
116
81
217
3.81
26.50
1.3
1.2
300.00
185.41
titre
0.36
12
37
507
3121
1.75
26.45
10.6
8.6
95.28
95.54
%
0.35
487
3010
2783
25521
1.96
26.17
42.8
17.0
24.71
25.35
mg/l
0.53
2581
21220
52
100
5.27
25.78
2.9
2.5
0.59
0.61
mmol/l
0.94
52
100
156
630
2.55
25.29
2.7
1.5
335.58
766.19
e6/l
0.83
130
494
2019
17155
1.52
25.12
5.8
3.4
71.85
51.08
u/l
11.48
1917
16068
154
623
2.55
24.88
2.7
1.5
53.04
36.60
e6/l
0.14
120
461
223
1066
2.18
24.61
2.6
2.1
432.89
661.58
ug/l
0.53
212
1012
2393
21157
1.59
24.38
52.3
20.8
14.59
13.68
%
101.97
2383
20874
1349
10653
1.47
23.58
5.5
3.9
0.01
0.09
estimate
1.12
518
2545
169
732
2.38
23.56
1.5
1.2
3.31
3.33
u/ml
0.01
22
57
51
105
4.92
23.42
1.3
1.1
78.60
9.63
u/ml
—
5
8
175
778
2.32
23.00
1.5
1.2
35.12
39.90
u/ml
0.09
16
33
461
2881
1.71
22.50
11.7
9.1
112.50
121.63
g/l
15.74
451
2807
371
2188
1.79
22.20
5.7
4.3
99.43
92.56
ng/l
0.65
322
1907
39
66
5.97
22.14
1.5
1.3
14.25
24.89
g/l
4.10
31
51
166
735
2.33
22.02
1.5
1.2
16.51
7.79
u/ml
0.47
31
99
94
314
3.06
21.83
1.5
1.8
—
1505.45
—
0
11
141
583
2.49
21.77
2.9
1.4
—
—
—
0
0
94
318
3.02
21.36
2.7
1.4
—
—
—
0
0
97
336
2.95
21.15
2.3
2.3
1.61
1.40
g/24h
0.16
66
197
137
572
2.46
20.72
1.5
1.2
56.57
48.58
u/ml
0.22
26
50
160
719
2.29
20.51
2.6
1.4
611.50
577.85
mg/l
0.27
153
683
43
86
5.06
20.43
3.2
4.8
—
—
—
0
0
476
3083
1.64
20.11
1.4
1.4
—
—
—
0
0
73
220
3.37
20.10
1.6
1.3
2.46
2.18
mmol/l
0.39
68
206
94
330
2.91
20.02
1.1
1.2
—
—
—
0
0
161
737
2.25
19.76
3.9
3.4
3.45
2.02
index
0.94
101
382
91
321
2.89
19.22
4.8
6.1
8.34
7.35
mmol/l
0.31
81
273
313
1829
1.79
19.22
12.0
10.6
23.88
24.20
mmol/l
1.02
307
1790
144
640
2.31
18.95
2.6
1.3
3.74
3.78
mmol/l
0.12
133
602
816
6035
1.48
18.90
1.4
1.3
2.98
1.48
u/ml
1.31
197
1600
75
243
3.14
18.39
1.4
1.1
—
—
—
0
0
71
224
3.22
18.19
1.1
1.0
286.25
285.97
mg/l
0.01
65
203
258
1447
1.85
18.09
7.4
4.8
—
—
—
0
0
30
48
6.30
18.00
1.2
1.3
60.33
159.14
titre
—
6
7
128
553
2.37
17.98
1.8
1.4
63.50
61.34
mmol/l
0.19
94
442
1300
10544
1.40
17.98
2.4
2.2
—
—
—
0
0
203
1055
1.99
17.89
3.6
3.4
611.08
4040.92
u/ml
0.73
170
916
140
632
2.27
17.78
3.8
3.4
295.33
795.90
u/ml
0.58
123
588
749
5508
1.48
17.67
4.7
4.1
427.75
630.57
ng/l
0.50
621
4435
104
412
2.58
17.60
1.5
1.5
31.01
32.18
g/l
0.46
96
371
39
82
4.80
17.52
1.5
1.2
30.55
20.79
%
0.36
11
14
174
863
2.08
17.44
1.5
1.4
263.48
275.87
ug/g
0.33
99
521
163
794
2.11
17.14
5.7
3.2
63.68
61.43
%
0.63
154
770
85
310
2.79
16.92
1.5
1.2
51.37
69.34
u/ml
—
6
14
66
209
3.20
16.83
1.1
1.1
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
62
195
3.22
16.00
1.1
1.1
—
—
—
0
0
962
7525
1.41
15.92
3.7
3.1
0.21
0.04
0.58
19
192
2780
26120
1.68
15.53
44.2
20.4
139.16
139.65
mmol/l
17.52
2750
25617
84
320
2.67
15.41
1.5
1.5
—
—
—
0
0
2780
26157
1.66
14.98
45.4
20.6
3.99
3.99
mmol/l
0.03
2745
25610
94
388
2.47
14.65
1.2
1.2
—
—
—
0
0
483
3364
1.52
14.58
2.6
2.5
154.64
138.08
ug/g
0.47
401
2690
841
6586
1.38
13.36
4.3
3.8
0.00
0.11
—
5
73
45
130
3.50
13.32
1.7
1.4
66.40
69.20
%
—
10
20
260
1598
1.68
13.25
5.5
3.0
0.65
0.61
%
1.48
260
1589
299
1907
1.63
13.20
5.8
3.3
115.22
129.03
g/l
17.63
291
1848
201
1150
1.80
13.20
8.0
5.2
24.86
24.68
mmol/l
0.45
190
1073
27
53
5.13
13.15
2.0
2.0
—
—
—
0
0
144
741
1.99
13.09
1.3
1.3
184.23
228.91
miu/ml
0.66
47
322
262
1621
1.67
13.02
5.7
3.0
1.28
1.20
%
0.86
262
1610
80
324
2.51
13.02
1.5
1.4
5.99
6.48
mmol/l
0.89
74
306
75
295
2.58
12.96
1.9
2.1
—
—
—
0
0
23
20
11.58
12.79
3.4
1.7
58.91
58.07
%
0.02
11
15
30
67
4.51
12.59
1.2
1.2
31.47
28.01
s
1.11
30
67
299
1929
1.61
12.59
13.4
10.7
0.65
0.63
%
0.60
293
1918
77
315
2.48
12.28
1.6
1.6
—
—
—
0
0
305
1999
1.58
12.01
12.8
10.4
1.44
1.30
%
1.29
299
1988
49
163
3.04
11.60
2.3
2.1
522.09
502.05
min
0.51
35
116
51
174
2.96
11.56
1.9
1.6
—
—
—
0
0
279
1808
1.60
11.52
9.3
6.7
24.48
24.45
mmol/l
0.04
263
1726
34
90
3.81
11.45
1.7
1.6
1991.11
3261.54
titre
—
9
13
80
345
2.35
11.40
1.1
1.2
104.66
113.91
%
1.29
71
314
22
41
5.40
11.34
2.8
3.2
48.57
22.61
mg/l
—
6
14
132
694
1.94
11.32
1.3
1.1
—
—
—
0
0
43
137
3.17
10.96
1.4
1.7
—
—
—
0
0
32
85
3.79
10.74
1.3
1.2
—
—
—
0
0
267
1743
1.58
10.68
15.1
11.0
14.83
15.98
%
8.39
258
1674
76
332
2.32
10.54
1.2
1.2
—
—
—
0
0
23
30
7.71
10.37
1.6
1.5
—
—
—
0
0
2170
19871
1.31
10.32
4.7
4.3
14.94
14.84
pmol/l
1.04
2012
18142
19
18
10.61
10.26
3.7
1.6
13.00
21.91
%
—
7
11
165
963
1.75
10.17
4.4
3.7
1.43
1.38
mmol/l
0.25
155
953
190
1155
1.69
10.11
2.3
2.7
—
—
—
0
0
223
1414
1.62
10.07
2.4
2.4
—
—
—
0
0
343
2397
1.48
10.02
3.4
2.5
0.63
0.45
e6/l
0.73
336
2303
28
72
3.91
9.84
1.4
1.3
—
—
—
0
0
115
609
1.92
9.70
3.1
3.4
0.79
0.82
nmol/l
0.34
80
495
26
64
4.09
9.69
3.8
2.8
424.58
538.59
ug/l
0.07
26
64
80
372
2.18
9.60
1.5
1.4
1177.67
4014.91
e6/l
0.61
60
250
258
1720
1.55
9.41
1.4
1.3
409.88
224.63
u/ml
1.08
223
1599
597
4680
1.34
8.93
1.3
1.3
44.10
33.24
iu/ml
0.58
186
1408
54
219
2.49
8.87
2.3
2.3
756.46
630.41
ml
1.17
39
141
484
3688
1.37
8.68
1.4
1.3
—
—
—
0
0
167
1027
1.66
8.54
3.6
3.7
367.92
384.06
mg/l
0.07
99
462
50
200
2.52
8.47
1.5
1.5
1805.04
1910.86
ml
0.38
50
195
187
1189
1.61
8.38
1.2
1.2
—
—
—
0
0
129
747
1.76
8.22
1.3
1.2
—
—
—
0
0
45
174
2.61
8.17
2.2
2.5
13.69
16.37
%
5.77
45
174
69
325
2.15
8.07
1.4
1.4
57568.10
91172.34
e6/l
0.41
41
177
34
114
3.00
8.03
1.8
1.8
—
—
—
0
0
44
170
2.61
8.01
1.5
1.3
7.41
7.40
ph
0.10
33
119
2785
26741
1.44
7.93
27.1
12.3
27.45
26.17
u/l
1.81
2745
25943
70
335
2.11
7.88
1.7
1.4
279.88
277.52
mosm/kgh2o
0.30
56
246
360
2660
1.40
7.75
2.5
2.1
0.00
0.01
estimate
0.78
74
552
36
128
2.83
7.68
1.1
1.1
—
5.29
iu/ml
—
0
7
66
313
2.13
7.61
1.5
1.4
—
—
—
0
0
57
256
2.25
7.52
4.1
3.5
11.27
11.44
index
0.04
44
151
35
125
2.82
7.42
1.1
1.1
1172.50
1444.23
miu/ml
0.87
35
125
38
142
2.70
7.41
1.6
1.6
1.86
2.52
u/field
0.29
29
103
15
18
8.37
7.31
1.3
1.4
1.38
1.03
iu/ml
—
8
6
204
1374
1.52
7.14
5.3
3.3
24.64
25.23
mmol/l
1.73
198
1321
33
117
2.84
7.10
1.1
1.1
361.00
197.35
iu/ml
0.74
33
117
121
719
1.71
7.09
1.6
1.5
12.84
8.83
u/l
1.83
95
581
14
16
8.78
7.04
1.0
1.0
—
—
—
0
0
2803
27023
1.43
7.03
49.5
22.2
86.13
79.97
umol/l
9.16
2782
26706
42
170
2.49
7.00
1.4
1.3
—
—
—
0
0
207
1405
1.51
6.99
4.2
3.4
1.02
1.02
ratio
0.41
197
1281
290
2107
1.42
6.88
1.2
1.2
—
—
—
0
0
355
2675
1.37
6.78
8.6
4.4
7.37
7.36
ph
0.94
300
1918
48
211
2.29
6.69
2.0
1.4
1.15
1.17
promille
0.04
42
166
49
220
2.25
6.51
1.2
1.1
—
—
—
0
0
2490
23650
1.28
6.48
5.9
5.3
2.00
1.95
mu/l
1.10
2339
21802
46
202
2.30
6.44
2.3
1.3
31.40
34.95
mmol/l
0.47
41
180
195
1341
1.48
6.20
7.8
5.1
1.63
1.59
%
0.28
182
1259
166
2437
0.66
6.20
2.1
2.0
3.57
3.48
ratio
0.35
127
1905
59
293
2.03
6.10
2.1
2.5
10.85
9.63
umol/l
0.16
46
206
60
301
2.01
6.04
4.5
1.6
—
—
—
0
0
179
1220
1.50
5.96
8.7
5.4
0.85
0.87
%
0.35
169
1145
30
112
2.69
5.91
3.2
1.7
37.44
40.03
g/l
1.04
30
112
61
317
1.94
5.59
3.8
2.5
1.20
1.19
mmol/l
0.15
61
312
1072
9450
1.21
5.57
4.7
3.8
—
0.68
—
0
31
194
1363
1.45
5.56
2.7
2.2
0.02
0.62
estimate
0.49
57
408
16
42
3.82
5.53
1.8
1.5
—
—
—
0
0
305
2318
1.35
5.52
3.5
3.0
287.67
209.38
ng/l
2.15
284
2127
17
47
3.63
5.48
1.1
1.1
—
—
—
0
0
40
179
2.25
5.41
2.5
2.2
7.92
8.25
mmol/l
0.20
40
179
61
325
1.89
5.22
3.8
2.4
105.95
105.51
mmol/l
0.35
61
320
61
325
1.89
5.22
3.8
2.4
4.05
4.08
mmol/l
0.25
61
320
318
2453
1.33
5.21
2.3
2.4
10.28
7.55
ug/l
0.90
277
2167
32
132
2.44
5.20
1.1
1.2
—
—
—
0
0
37
165
2.26
5.07
1.3
1.1
—
—
—
0
0
10
12
8.35
5.05
3.0
4.4
—
—
—
0
0
175
1231
1.45
5.01
1.2
1.1
177.50
135.84
titre
—
8
25
106
670
1.60
4.99
4.9
4.3
—
—
—
0
0
57
302
1.90
4.97
1.2
1.2
—
—
—
0
0
60
325
1.86
4.90
1.5
1.2
—
—
—
0
0
32
136
2.37
4.90
3.3
2.9
—
—
—
0
0
960
10786
0.84
4.71
2.2
1.9
1.43
1.35
mmol/l
1.61
792
9061
526
4384
1.24
4.66
1.3
1.3
16.99
11.33
u/ml
0.65
164
1651
1048
9335
1.19
4.66
5.1
4.2
12.21
10.43
mg/mmol
0.33
709
5970
1086
9728
1.18
4.48
4.3
3.5
7.13
7.66
mmol/l
3.60
932
8222
16
49
3.28
4.46
1.8
1.6
4.09
9.48
%
1.39
11
25
75
448
1.69
4.44
1.8
1.9
4.37
4.83
mmol/24h
0.57
68
395
124
1791
0.68
4.31
1.8
1.8
3.38
3.45
mmol/l
0.31
80
1258
114
764
1.51
4.21
2.5
2.3
6678.24
5642.88
u/l
0.11
44
316
117
790
1.50
4.17
4.9
3.9
3.87
3.93
mmol/l
0.54
111
784
63
366
1.74
4.14
1.5
1.6
23.23
27.97
ng/l
0.60
63
366
45
236
1.92
4.10
1.7
1.5
29.14
27.93
%
0.08
29
141
161
1160
1.41
4.09
7.7
3.4
74.00
70.99
u/ml
0.05
156
1120
1020
9151
1.17
4.03
4.0
3.6
66.32
47.87
mg/l
1.81
724
6022
27
117
2.32
4.01
1.3
1.1
1721.42
215.40
ng/l
0.62
12
30
125
866
1.46
3.94
9.7
6.1
1.37
1.34
mmol/l
0.15
99
756
8
11
7.29
3.86
1.8
1.4
—
—
—
0
0
205
1553
1.34
3.85
3.5
3.5
4.24
4.48
pmol/l
2.46
188
1376
54
309
1.76
3.77
1.7
1.6
62.31
61.36
%
0.06
35
191
2829
27634
1.30
3.73
64.3
25.7
6.42
6.82
e9/l
5.39
2788
26959
2828
27625
1.30
3.71
64.2
25.6
92.39
91.20
fl
25.17
2808
27312
2828
27627
1.30
3.69
64.1
25.5
30.66
30.36
pg
11.56
2808
27312
2828
27628
1.30
3.68
65.6
26.2
37.52
40.38
%
45.36
2808
27301
2828
27628
1.30
3.68
64.3
25.6
4.14
4.48
e12/l
132.43
2785
26957
2827
27619
1.29
3.67
64.5
25.7
162.85
247.68
e9/l
307.65
2786
27038
2828
27634
1.29
3.63
64.9
25.8
124.70
134.85
g/l
153.83
2809
27326
21
85
2.48
3.62
1.2
1.3
357.04
112.93
ug/l
0.29
11
38
29
136
2.14
3.60
2.7
2.0
29.28
27.08
umol/l
0.38
29
125
141
1022
1.40
3.51
1.5
1.4
30.01
25.81
iu/l
0.65
111
858
21
87
2.42
3.46
1.0
1.0
—
—
—
0
0
21
87
2.42
3.46
1.0
1.0
—
—
—
0
0
21
87
2.42
3.46
1.0
1.0
—
—
—
0
0
39
208
1.89
3.44
1.2
1.1
61.11
41.50
mg/l
1.13
27
171
143
1929
0.73
3.40
1.3
1.4
—
—
—
0
0
9
18
5.01
3.37
1.0
1.0
—
—
—
0
0
9
18
5.01
3.37
1.0
1.0
—
—
—
0
0
103
714
1.46
3.29
1.8
1.6
18326.65
14211.70
e6/l
0.40
77
489
13
43
3.03
3.25
1.9
2.9
—
—
—
0
0
11
29
3.80
3.18
1.1
1.0
—
—
—
0
0
30
153
1.97
3.04
1.5
1.2
0.46
0.54
ratio
1.19
13
88
7
12
5.84
3.02
1.9
1.1
—
—
—
0
0
46
751
0.61
2.92
1.1
1.1
0.57
0.64
ratio
—
8
97
213
1694
1.28
2.87
1.2
1.2
147.55
144.66
u/ml
0.04
74
615
36
201
1.80
2.81
1.1
1.1
361.90
280.80
mg/l
0.70
29
174
43
254
1.70
2.77
1.4
1.6
3.42
4.31
ug/l
0.38
36
225
41
239
1.72
2.77
2.7
2.1
1.77
1.66
u/field
0.05
26
129
36
202
1.79
2.77
1.3
1.2
335.26
363.20
nmol/l
0.33
31
174
8
19
4.22
2.67
1.1
1.0
—
—
—
0
0
8
19
4.22
2.67
1.4
1.2
—
—
—
0
0
9
24
3.76
2.67
1.1
1.0
—
—
—
0
0
20
92
2.18
2.67
1.1
1.1
—
—
—
0
0
38
220
1.74
2.64
1.2
1.2
104.66
104.17
pmol/l
0.02
38
220
17
74
2.30
2.57
1.0
1.0
—
—
—
0
0
25
131
1.92
2.40
2.7
3.4
—
—
—
0
0
11
40
2.76
2.27
1.4
1.5
—
—
—
0
0
58
392
1.49
2.21
6.5
5.4
405.46
353.99
umol/l
1.67
48
353
258
2164
1.21
2.21
2.7
2.7
6.07
6.07
ph
0.00
196
1489
7
19
3.69
2.15
1.4
1.2
—
—
—
0
0
13
55
2.37
2.12
1.3
1.5
—
—
—
0
0
198
1629
1.23
2.06
1.4
1.3
64.85
56.36
au/ml
0.19
11
111
89
661
1.36
2.04
2.8
2.3
173.25
104.65
ug/min
0.80
57
406
81
593
1.38
2.03
12.5
7.1
11.03
11.29
mmol/l
0.32
70
523
81
594
1.37
2.01
12.5
7.1
105.29
105.28
mmol/l
0.00
70
524
11
44
2.50
2.01
2.4
1.1
—
—
—
0
0
11
44
2.50
2.01
2.3
1.1
—
—
—
0
0
11
44
2.50
2.01
2.4
1.1
—
—
—
0
0
19
97
1.96
2.00
2.7
2.5
171.09
103.39
ug/l
0.15
19
87
56
386
1.46
1.97
1.3
1.3
—
—
—
0
0
80
1066
0.74
1.88
1.8
1.7
—
—
—
0
0
22
121
1.82
1.88
2.9
3.5
—
—
—
0
0
56
391
1.44
1.86
8.8
2.5
—
—
—
0
0
6
17
3.53
1.83
1.2
2.2
—
—
—
0
0
18
94
1.92
1.80
2.1
2.0
—
—
—
0
0
7
23
3.05
1.80
1.3
1.1
—
—
—
0
0
18
95
1.90
1.75
1.3
1.8
0.00
0.06
estimate
0.80
18
95
13
61
2.14
1.71
1.3
1.2
—
—
—
0
0
33
210
1.58
1.70
2.8
2.7
21.35
32.30
mg/l
1.54
23
153
687
6321
1.11
1.67
5.4
4.1
1.02
1.25
kg/l
0.50
503
4249
6
20
3.00
1.58
1.0
1.1
—
—
—
0
0
10
44
2.28
1.55
10.4
11.9
9.27
5.87
mmol/l
—
10
44
76
579
1.32
1.54
4.6
3.6
30.64
29.17
mg/l
0.13
64
405
209
1786
1.18
1.53
2.7
2.4
33.23
20.14
au/ml
0.47
14
166
24
146
1.65
1.50
1.0
1.3
127.21
138.23
nmol/l
0.39
24
146
5
16
3.13
1.44
2.0
1.6
—
—
—
0
0
15
81
1.86
1.40
1.2
1.2
9.11
8.97
pmol/l
—
6
30
36
515
0.70
1.37
1.8
1.7
—
—
—
0
0
6
23
2.61
1.36
1.0
1.1
—
23.57
—
0
7
6
23
2.61
1.36
1.3
1.2
—
—
—
0
0
6
24
2.50
1.30
1.7
1.1
—
—
—
0
0
60
456
1.32
1.28
1.2
1.1
3.52
18.09
au/ml
—
5
100
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
13
69
1.89
1.28
9.2
6.2
6.53
5.35
kpa
0.69
13
69
17
99
1.72
1.27
1.4
2.8
1.19
1.41
ug/l
0.27
17
91
66
516
1.28
1.17
1.7
2.0
—
—
—
0
0
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
51
386
1.33
1.15
1.4
1.5
—
—
—
0
0
52
395
1.32
1.14
1.5
1.6
—
—
—
0
0
22
142
1.55
1.14
2.4
2.7
47.60
48.75
umol/l
—
5
13
65
510
1.28
1.13
1.4
1.5
70.80
63.12
ug/l
0.32
50
436
50
379
1.32
1.12
1.4
1.5
1.20
1.29
mm
0.76
34
278
5
21
2.38
1.09
1.0
1.2
334.20
353.57
umol/24h
—
5
21
47
355
1.33
1.08
1.7
1.4
0.95
0.34
nmol/l
0.60
34
275
15
89
1.69
1.07
2.7
3.9
9.15
8.19
mg/l
—
8
77
11
59
1.87
1.07
3.3
2.3
7.90
7.92
mmol/l
—
5
32
106
892
1.19
1.00
1.5
1.6
1078.49
1019.09
mu/l
0.23
86
754
9
48
1.88
1.00
1.4
1.1
—
—
—
0
0
1076
10303
1.07
0.99
5.4
5.8
3.36
3.48
ug/l
0.06
942
9296
79
648
1.22
0.98
1.1
1.1
1.00
6.92
eliau/ml
—
6
73
72
585
1.24
0.97
1.8
1.8
1.00
0.86
nmol/l
0.86
63
480
57
452
1.27
0.95
1.4
1.1
—
—
—
0
0
6
27
2.22
0.93
2.3
2.9
0.00
0.67
u/field
—
6
27
47
365
1.29
0.92
1.2
1.2
—
—
—
0
0
36
476
0.75
0.92
1.1
1.1
0.81
1.44
u/ml
0.56
15
228
6
29
2.07
0.89
2.0
1.5
—
—
—
0
0
34
255
1.34
0.86
1.2
1.1
—
—
—
0
0
8
44
1.82
0.85
5.5
5.8
10.00
8.20
%
—
8
44
8
44
1.82
0.85
2.8
2.9
47.75
41.86
%
—
8
44
56
451
1.25
0.84
1.4
1.1
—
—
—
0
0
300
3263
0.91
0.83
4.6
5.0
31.57
32.48
%
0.70
217
2135
11
65
1.69
0.82
1.3
1.6
0.38
0.48
e9/l
0.76
11
65
25
180
1.39
0.81
1.0
1.1
13.76
16.27
u/ml
—
7
64
98
844
1.17
0.76
1.7
1.7
375.04
297.84
mu/l
0.78
91
772
42
332
1.27
0.76
1.0
1.1
9.31
2.64
eliau/ml
0.40
13
131
18
124
1.45
0.75
1.4
3.1
66.18
122.29
umol/l
1.27
11
76
5
25
2.00
0.72
2.4
3.2
0.84
0.61
ug/l
—
5
25
26
343
0.76
0.70
1.0
1.0
0.16
0.28
u/ml
—
10
130
2441
24705
0.94
0.69
5.2
5.1
1.35
1.44
mmol/l
18.61
2225
22852
2498
25263
0.94
0.69
5.9
5.9
2.47
2.64
mmol/l
17.98
2292
23429
39
486
0.80
0.68
1.1
1.1
1.89
4.66
u/ml
2.53
20
278
58
691
0.84
0.66
1.1
1.2
—
—
—
0
0
29
223
1.30
0.66
1.4
1.4
0.94
3.13
u/ml
1.24
15
127
16
111
1.44
0.65
1.3
1.3
148.88
170.28
mmol/24h
0.49
16
111
5
29
1.72
0.64
1.0
1.2
1.62
1.94
umol/24h
—
5
29
76
880
0.86
0.63
1.9
1.9
49.41
41.91
nmol/l
1.51
76
847
72
618
1.17
0.62
13.3
2.5
—
—
—
0
0
20
147
1.36
0.61
2.0
1.6
—
—
—
0
0
47
564
0.83
0.60
1.2
1.1
0.78
2.79
u/ml
3.33
29
322
8
53
1.51
0.58
1.8
1.5
—
—
—
0
0
16
115
1.39
0.56
1.2
1.2
13.81
9.47
mm/h
0.45
16
115
95
842
1.13
0.55
5.7
2.0
—
—
—
0
0
229
2456
0.93
0.51
1.6
1.5
—
—
—
0
0
71
810
0.87
0.51
22.4
10.7
—
—
—
0
0
2468
24444
1.05
0.48
5.9
5.3
6.08
5.98
mmol/l
2.29
2272
22337
63
554
1.14
0.44
1.4
1.3
—
—
—
0
0
8
58
1.38
0.41
1.0
1.1
26.26
38.32
iu/ml
—
8
58
99
900
1.10
0.41
5.5
2.0
—
—
—
0
0
102
1115
0.91
0.39
1.1
1.1
—
—
—
0
0
10
71
1.41
0.39
2.5
2.3
—
—
—
0
0
40
463
0.86
0.38
1.1
1.1
0.73
1.78
u/ml
1.50
17
254
28
235
1.19
0.36
5.0
5.2
33.57
34.36
u/ml
—
7
68
14
179
0.78
0.35
1.6
1.4
132.36
213.87
pmol/l
0.76
14
179
99
909
1.09
0.35
5.6
2.0
—
—
—
0
0
33
384
0.86
0.35
1.0
1.1
6.13
3.91
u/ml
0.16
16
205
18
146
1.23
0.32
7.1
7.0
4.04
141.90
ug/l
—
10
94
98
905
1.09
0.32
5.6
2.0
—
—
—
0
0
23
193
1.19
0.30
1.0
1.1
8.72
8.98
iu/ml
—
9
48
22
184
1.20
0.30
1.7
2.1
6.43
6.85
mmol/l
0.31
16
122
76
825
0.92
0.28
1.1
1.1
—
—
—
0
0
10
76
1.32
0.28
1.9
1.4
9.33
8.67
mmol/l
—
10
76
96
894
1.08
0.27
5.6
1.9
—
—
—
0
0
37
328
1.13
0.26
1.6
1.3
0.21
0.19
nmol/l
0.53
27
262
42
376
1.12
0.26
1.6
1.4
0.65
5.38
nmol/l
0.50
42
359
49
443
1.11
0.26
1.1
1.1
1.60
122.71
iu/ml
—
5
90
2377
23616
1.03
0.26
4.7
4.4
1.32
1.28
mmol/l
1.84
2173
21620
2474
24872
0.97
0.25
5.4
5.2
4.28
4.53
mmol/l
25.87
2273
23171
13
157
0.83
0.22
1.0
1.1
11.43
1.42
u/ml
—
7
67
0
12
0.00
0.21
0.0
1.1
—
0.04
—
0
12
0
12
0.00
0.21
0.0
1.2
—
0.16
—
0
12
133
1272
1.05
0.19
2.3
2.0
—
—
—
0
0
10
82
1.22
0.17
1.7
1.5
81.50
490.44
nmol/24h
—
10
82
7
63
1.11
0.17
1.4
1.4
103.64
55.46
mu/l
—
7
50
33
360
0.92
0.16
1.0
1.1
3.20
5.00
u/ml
0.46
14
174
29
264
1.10
0.15
2.1
1.6
389.83
324.82
mu/l
0.34
24
213
604
6123
0.98
0.13
3.2
3.4
0.89
0.78
ug/l
0.61
422
4162
2103
21121
0.99
0.13
50.2
21.8
331.41
332.36
g/l
4.29
2090
20989
34
317
1.07
0.12
1.6
1.3
—
—
nmol/l
—
0
0
19
173
1.10
0.10
1.1
1.0
—
—
—
0
0
21
193
1.09
0.09
2.0
1.5
98.71
84.73
umol/l
0.85
21
193
5
48
1.04
0.09
1.2
1.5
0.02
1.60
u/ml
—
5
48
33
311
1.06
0.09
1.8
1.8
—
—
—
0
0
74
716
1.03
0.08
2.2
2.0
15.28
11.88
iu/l
0.09
33
291
6
70
0.86
0.07
1.0
1.0
10.55
9.24
mu/l
—
6
63
24
225
1.07
0.07
3.3
3.2
13.28
35.39
mg/l
1.59
16
169
20
186
1.08
0.07
1.2
1.2
—
—
—
0
0
927
9318
0.99
0.06
3.5
3.2
—
—
—
0
0
2406
24012
1.01
0.06
7.2
6.6
39.17
39.57
mmol/mol
1.33
2235
22391
14
152
0.92
0.06
1.0
1.2
3.45
2.22
u/ml
—
6
53
19
203
0.94
0.06
1.0
1.0
702.43
692.05
ng/l
0.03
14
131
19
202
0.94
0.05
1.0
1.0
253.64
308.64
ng/l
0.51
14
133
29
279
1.04
0.04
2.1
2.4
—
—
—
0
0
30
311
0.96
0.03
3.0
2.6
—
—
—
0
0
36
351
1.03
0.02
2.1
2.2
15.18
20.73
mg/l
0.51
11
126
17
164
1.04
0.00
2.7
1.9
119.18
123.05
ng/l
0.06
17
164
12
116
1.03
0.00
1.2
1.1
—
—
—
0
0
30
295
1.02
0.00
1.5
1.3
7.65
7.49
mmol/l
0.09
25
259
251
2510
1.00
0.00
2.3
2.3
12.60
13.01
nmol/l
0.28
222
2256
5
56
0.89
0.00
1.0
1.1
0.38
5.93
u/ml
—
5
50
0
6
0.00
-0.00
0.0
1.5
—
46.92
—
0
6
6
59
1.02
-0.00
1.0
1.2
—
—
—
0
0
5
52
0.96
-0.00
1.6
2.2
9.98
16.71
umol/l
—
5
52
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
8.45
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
3220.00
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_THROMBOCYTOPENIANAS and mortality.

Females

Parameter HR [95% CI] p-value
D3_THROMBOCYTOPENIANAS 2.959 [2.61, 3.36] < 0.001
Birth year 0.995 [0.99, 1.0] 0.239

During the follow-up period (1.1.1998 — 31.12.2019), 2428 out of 7148 females with D3_THROMBOCYTOPENIANAS died.

Males

Parameter HR [95% CI] p-value
D3_THROMBOCYTOPENIANAS 3.095 [2.72, 3.52] < 0.001
Birth year 0.997 [0.99, 1.01] 0.474

During the follow-up period (1.1.1998 — 31.12.2019), 3444 out of 8372 males with D3_THROMBOCYTOPENIANAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_THROMBOCYTOPENIANAS.

N-year risk Females Males
1 0.242% 0.6%
5 1.655% 4.353%
10 4.4% 10.977%
15 8.294% 19.863%
20 14.628% 32.578%

Relationships between endpoints

↥

Index endpoint: D3_THROMBOCYTOPENIANAS – Thrombocytopenia, unspecified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data